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Selective gene expression is crucial in maintaining the self-renewing and 
multipotent properties of stem cells. Mediator is a large, evolutionarily conserved, multi-
subunit protein complex that modulates gene expression by relaying signals from cell 
type-specific transcription factors to RNA polymerase II. In humans, this complex 
consists of 30 subunits arranged in four modules: head, middle, tail, and kinase. In our 
introduction, we show the state of the field of Mediator study with a focus on the critical 
kinase module. In the following chapters, we used siRNA knockdowns to investigate the 
roles of the highly-conserved core subunit MED31 and the kinase module subunit 
MED12 in directing cell state in human adult-derived mesenchymal stem cells harvested 
from either bone marrow or adipose tissue. Knockdown of MED31 resulted in a decrease 
in self-renewal based on cell assays and monitoring of gene expression and lipid vesicle 
formation. MED12 knockdown has produced similar results, but a potential interaction 
between MED12 and the master regulator of adipogenesis, PPARG, has been revealed 
through the application of delayed knockdown assays. These studies seek to expand our 
current understanding of stem cell behavior and how it relates to the critical Mediator 
complex in order to further progress toward stem cell therapies. In our final chapter, we 
show bioinformatics techniques that are rapidly transforming the field of biology that will 
also greatly impact the study of the Mediator complex in human stem cells. 
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“In the beginning was the Word, and the Word was with God, and the Word was 
God. The same was in the beginning with God. All things were made by him; and without 
him was not any thing made that was made. In him was life; and the life was the light of 
men. And the light shineth in darkness; and the darkness comprehended it not. There was 
a man sent from God, whose name was John. The same came for a witness, to bear 
witness of the Light, that all men through him might believe. He was not that Light, but 
was sent to bear witness of that Light. That was the true Light, which lighteth every man 
that cometh into the world. He was in the world, and the world was made by him, and the 
world knew him not. He came unto his own, and his own received him not. But as many 
as received him, to them gave he power to become the sons of God, even to them that 
believe on his name: Which were born, not of blood, nor of the will of the flesh, nor of the 
will of man, but of God. And the Word was made flesh, and dwelt among us, (and we 
beheld his glory, the glory as of the only begotten of the Father,) full of grace and truth. 
John bare witness of him, and cried, saying, This was he of whom I spake, He that 
cometh after me is preferred before me: for he was before me. And of his fulness have all 
we received, and grace for grace. For the law was given by Moses, but grace and truth 
came by Jesus Christ. No man hath seen God at any time, the only begotten Son, which is 
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1.1 Mediator and Gene Expression 
1.1.1 Background 
Our understanding of genomics and transcriptomics has advanced considerably in 
the last thirty years. The Human Genome Project, exponential increases in computing 
power, and the advent of next-generation sequencing have formed a solid foundation 
upon which to study the transcriptome: the gateway between the potentiality of genomic 
information and the actuality of cellular protein expression. Regulation of cell type-
specific transcription is the key to that gateway, and the keeper of the key is the Mediator 
complex. The Mediator complex is a highly conserved transcriptional regulatory complex 
composed of many subunits divided into four modules, and it facilitates the convergence 
of environment, signaling cascades, cell type-specific transcription factors, and core 
transcriptional machinery to control cell state1–3. Mediator’s activity is associated with 
recently characterized super-enhancers and their interaction with Mediator’s four 
modules. 
Perhaps the most poorly understood aspect of Mediator is its kinase module 
composed of the subunit 12 or 12-like (MED12/L), subunit 13 or 13-like (MED13/L), 
cyclin dependent kinase 8 or 19 (CDK8/19), and Cyclin C (CCNC). The final step in 
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deciphering Mediator’s role in cell fate determination may lie in the greater 
understanding of this enigmatic module. Stem cells offer a unique opportunity to delve 
deeper into the role of Mediator and the kinase domain as these cells are normal, self-
renew, and differentiate4,5. Despite their incredible clinical relevance, particularly in the 
fields of regenerative therapy and tissue engineering, there are still too many unanswered 
questions that hinder their widespread clinical deployment, including questions about 
how the environment, signaling pathways, transcription factors, and Mediator work 
together to drive self-renewal and differentiation toward specific lineages. This 
introduction will describe the Mediator complex, its association with super-enhancers, its 
kinase module, and the kinase module’s role in controlling cell state and lineage 
commitment. The discussion of the kinase module will include its structure, function, 
association with disease, and role in regulating cell type specific transcription. Finally, 
this introduction will identify gaps that remain in our current understanding of the kinase 
module and point to those as opportunities for continued exploration. 
1.1.2 The Mediator Complex 
In 1990, around the time that the Human Genome Project was beginning in 
earnest, Roger Kornberg’s lab at Stanford University stumbled upon a phenomenon while 
studying transcription activation in S. cerevisiae. The work involved the potent activator 
GAL4-VP16 (a hybrid protein composed of GAL4’s DNA-binding domain and the 
activator portion of the herpes simplex VP-16 protein) and its in vitro inhibition of T-rich 
binding factor. GAL4-VP16 was responsible for activating genes with GAL4 binding 
sites while T-rich binding factor activated genes possessing thymine-rich regions. 
Reasonably, neither activator should have interfered with the activity of the other unless 
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an unknown coactivator was also required to complete the activation, and this coactivator 
was acting as a limiting reagent due to its low availability. This squelching between the 
two activators was relieved when S. cerevisiae protein fractions were added, indicating 
that there was indeed a novel coactivator at work. Neither RNA polymerase II (RNAP II) 
nor the general transcription factor TFIID proved to be this coactivator, and so the 
mysterious factor was at once named the Mediator of RNAP II Transcription, describing 
its observed function in the transcriptional process6,7 (for a more extensive history of 
Mediator’s discovery, see review by Kornberg)8. 
Over the next two decades, the Mediator complex was found to be universally 
conserved throughout all eukaryotic organisms while completely absent in prokaryotes. 
Eukaryotes, being far more complex than prokaryotes, owe their incredible complexity to 
the regulation of gene expression provided, in large part, by the Mediator complex8.  
Mediator is a large, 1 million Dalton8 protein complex composed of between 20-30 
subunits depending on species3, and is arranged in four distinct modules: head, middle, 
tail, and kinase9. Bioinformatic and biochemical analyses have identified most of the H. 
sapiens Mediator subunits as similar in sequence, structure, and function to those found 
in S. cerevisiae and D. melanogaster, indicating a high degree of sequence conservation 
across eukaryotic species10 (Figure 1-1). 
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Figure 1-1: Structural differences between S. cerevisiae (Yeast) and H. sapiens 
(Human) Mediator complex. Shared and highly conserved subunits are shown in blue, 
while additional subunits that exist in humans but not yeast are highlighted in orange. 
This includes subunits that can substitute for each other in the kinase domain, 
including CDK8/CDK19, MED12/MED12L, and MED13/MED13L. 
1.1.3 Mediator and Super-Enhancers 
In the past ten years, super-enhancers have been characterized as clustered 
enhancers whose combined influence over the cellular transcription program is greater 
than other known gene regulatory elements. The complexity and specificity of super-
enhancers make them critical components of identifying and characterizing cell type-
specific genes. Super-enhancers were initially defined in embryonic stem cells by Whyte 
et al. in 2013 as genomic elements occupied by 1) a significant number of cell type-
specific transcription factors such as OCT4, SOX2, and NANOG, 2) an abundance of the 
histone mark H3K27Ac, and perhaps most importantly, 3) the Mediator complex11. 
Traditionally, enhancers have been defined as regions of DNA spanning only a few 
hundred base pairs to which transcription factors bind. These elements occur with a 
frequency of one every 3,000 to 30,000 bases and are responsible for regulating the 
expression of a corresponding downstream gene by helping to recruit RNAP II to the 
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gene’s promoter12. The unique feature of super-enhancers is the high level of Mediator 
occupancy along with cell type-specific transcription factors when compared to typical 
enhancers. Because of this, the identification of super-enhancers hinges primarily on the 
presence of MED1, the largest and most highly conserved of the Mediator core 
subunits11. Using chromatin immunoprecipitation sequencing (ChIP-seq), enhancers are 
ranked by their MED1 enrichment and are plotted against the MED1 signal. All 
enhancers beyond the inflection point—where the slope of the generated line graph 
equals 1—are deemed super-enhancers and further investigated for co-occupancy by 
other identifiers13. Given the role of Mediator as a bridge between cell type-specific 
transcription factors and the transcriptional machinery, the detection of Mediator at the 
enhancer and promoter of cell type-specific genes confirms DNA looping14. In addition, 
it further identifies the promoter of a specific super-enhancer target gene (Figure 1-2), 
making Mediator a significant factor in identifying cell type-specific gene profiles and 
understanding transcriptional control that defines cell state11,15–20. 
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Figure 1-2: Top: Linear representation of a super-enhancer. Grey ovals represent 
DNA-bound transcription factors and orange circles represent the histone mark 
H3K27Ac with the gene promoter potentially located over 10 kilobases downstream 
of the super-enhancer. Bottom: DNA looping mediated by the Mediator complex and 
Cohesin leading to the expression of the downstream gene14. 
Understanding Mediator’s role in occupying enhancers and super-enhancers 
began as early as 2010 when Kagey et al. used shRNAs to reduce expression of Mediator 
and Cohesin—a protein complex involved in looping chromatin. The results of this study 
indicated a loss of pluripotency in murine embryonic stem cells (mESCs) following the 
knockdown of several Mediator subunits, most of the Cohesin subunits, and the Cohesin 
loading complex subunit Nipbl. ChIP-seq analysis revealed that Mediator and Cohesin 
co-occupied both the enhancers and promoters of key mESC regulators pou5f1 (the gene 
encoding OCT4) and nanog, indicating that Mediator was interacting with distant 
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enhancers and promoters simultaneously. Chromatin Conformation Capture (3C) assays 
further confirmed DNA looping between these enhancers and promoters, supporting a 
model for Mediator in which the complex reaches across a 3-dimensional chromatin 
landscape to activate the expression of stem cell transcription factors and cell type-
specific genes14. This work was later confirmed and expanded on in a series of 
publications from other laboratories21–25. 
In 2013, Whyte et al. performed ChIP-seq for OCT4, SOX2, and NANOG in 
murine embryonic stem cells and observed yet another novel pattern in genome 
occupancy. Of the 8,794 sites that were co-occupied by all three transcription factors, 231 
of those sites were also occupied by MED1 at levels at least ten-times higher than typical 
enhancers. In addition to patterns of transcription factor and co-factor occupancy, super-
enhancer-associated genes have higher rates of expression than genes associated with 
typical enhancers. To demonstrate this, a luciferase assay was performed where pou5f1 
was incorporated into either a cloned region from a typical enhancer or a super-enhancer. 
This study revealed at least a 3-fold increase in pou5f1 expression when coupled with the 
super-enhancer region compared to a typical enhancer region. Conversely, expression of 
genes associated with super-enhancers was found to be reduced by 0.5-fold in the 
absence of OCT4 or MED12, showing that super-enhancer regulation is indeed 
dependent on the presence of key transcription factors and Mediator11. 
Work in the same year—also performed in the lab of Dr. Richard Young at the 
Whitehead Institute—expanded the search for super-enhancers beyond murine embryonic 
stem cells. Hnisz et al. performed ChIP-seq for RNAP II and RNA-seq to monitor all 
transcripts, and their data revealed that super-enhancers are enriched for both RNAP II 
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and transcript with signals that are at least 24 times greater than those observed for 
typical enhancers. These data support the evidence initially provided by Whyte et al. that 
super-enhancer-associated genes are transcribed at higher levels. Finally, H3K27Ac 
histone marks were measured using ChIP-seq to identify super-enhancers in 86 human 
cells and tissue samples ranging from adipose and aorta tissue to small intestine and 
thymus tissue18. This line of exploration revealed that super-enhancers are not a unique 
feature of mouse and human ESCs but are indeed found in a host of cell types where they 
are associated with master transcription factors such as MYOD1 (myoblasts) and PPARG 
(adipocytes). Genome-wide association studies revealed that non-coding single 
nucleotide polymorphisms (SNPs) that are associated with phenotypic traits also occur 
disproportionately in super-enhancers. Some non-coding SNPs identified in super-
enhancers are linked with human diseases such as Alzheimer’s disease and type 1 
diabetes, and cancers like pancreatic cancer and colorectal cancer. Such research has 
further elucidated the importance of super-enhancers not only in the regulation of cell 
type specificity, but also in the onset and progression of disease and oncogenesis18. 
Given the interaction of Mediator with transcription factors, its regulation of cell 
type-specific gene expression, and its intimate relationship with super-enhancers, 
Aranda-Orgilles et al. sought to better understand the role of Mediator’s transient kinase 
module in the regulation of cell state; namely MED12’s role in the maintenance of 
hematopoietic stem cells (HSCs). First, MED12 knockouts were induced in mouse 
embryos, resulting in mortality of all knockout mice within a month. The knockdout of 
MED12 also reduced the growth of bone marrow and thymus tissue in these mice 
compared to the untreated control. Considering the interdependence of the kinase module 
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subunits, separate knockouts of MED13, CDK8, and CCNC (each discussed in further 
detail later) were performed in murine HSCs but none could replicate the severity of the 
MED12 knockout. This suggested MED12’s critical importance in maintaining HSC 
viability. The expression of HSC-specific genes decreased in the absence of MED12 
which indicated a role in regulating cell type-specificity. MED12 ChIP-seq was 
performed in human HSCs, and 84% of the sites found to be occupied by MED12 were 
located more than 10 kilobases from promoters. MED12 co-occupied genomic regions 
along with the enhancer-associated histone mark H3K27ac and the transcription factors 
RUNX1, FLI1, GATA2, and ERG. MED12 also occupied super-enhancers associated 
with hematopoietic-specific genes26. This line of research revealed that beyond the 
interaction of Mediator’s core with super-enhancers and promoters, Mediator’s four-
subunit kinase module is also quite active on its own in genome-wide transcription 
regulation and so deserving of more in-depth study. 
Despite all the previous findings, the exact mechanism for how signaling factors 
efficiently interact with transcription factors scattered across the enhancers and super-
enhancers of the genome remained poorly understood. More recently, Zamudio et al. 
initiated studies to determine how signaling factors, namely ß-catenin, interacted with 
chromatin, transcription factors, and Mediator to form condensates: three-dimensional 
pockets of enhancers and super-enhancers all interacting together to drive cell type-
specific gene transcription. RNA-FISH was performed to monitor the location of nanog 
transcripts and IF staining was used to confirm that the signaling factors ß-catenin, 
STAT3, SMAD3, and coactivator MED1 all localize to regions of nanog involved in 
activating transcription. ChIP-seq analysis confirmed that all four factors interact with the 
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nanog-associated super-enhancer27. The model for ß-catenin’s interaction with the nanog-
associated super-enhancer established by this research serves as an explanation for how 
signaling factors can simultaneously influence the expression of several genes important 
for the maintenance and development of stem cells. 
Taken together, these studies over the past ten years indicate a cooperativity 
between chromatin structure in the form of super-enhancers, the Mediator complex, and 
Mediator’s kinase module that is integral for the direction of cell type-specific gene 
transcription. Now that Mediator and super-enhancers form part of the foundation of 
transcription regulation, the outstanding question from our existing information involves 
the extent to which Mediator’s kinase module plays a role in the overall process of cell 
type determination, either in regulating Mediator itself, or as independent coactivating 
subunits, or both. 
1.2 Mediator’s Kinase Module and Role in Disease and Development 
1.2.1 The Mediator Kinase Module 
The Mediator complex exists in two forms: The Mediator complex with the 
kinase module (30 subunits) and the core Mediator (26 subunits), which lacks the four-
subunit kinase module. The 600 kDa kinase module is stable and able to exist and 
function independently of the core Mediator complex and can transiently associate with 
the core complex through MED138,37. The structural and functional aspects of the kinase 
module, including information on paralogs of the kinase module subunits and the 
importance of kinase activity in transcriptional regulation, is described below. 
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Structure and Function 
 A tightly organized network of both physical and functional subunit interactions 
maintains the structural integrity of the kinase module. Detailed studies of this complex 
structure have revealed the subunit organization within the kinase module, adding critical 
insight into the mechanism of CDK8’s enzymatic activity. Specifically, early electron 
microscopy analysis in S. cerevisiae showed the kinase module structure having two bent 
protruding ends, identified as CDK8-CCNC, MED13, and a central globular protein, 
MED12. This model correlated with the previously observed human kinase module 
structure, with both models confirming the connection of the kinase module to the 
Mediator core through MED13 (Figure 1-3)28. 
 
Figure 1-3: Mutually exclusive paralogs of subunits from the Mediator kinase 
domain. These paralogs, CDK19, MED12L, and MED13L, are replaced by CDK8, 
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MED12, and MED13 respectively under specific conditions, although the full details 
of how and why remain unknown. 
The association of the kinase module through MED13/MED13L allows for the 
adoption of different conformations and reversible interactions not just with the core 
Mediator but with other factors involved in transcription and cell state regulation29. In 
addition, physical interactions between kinase module subunits and the core Mediator 
leads to the adoption of different complex conformations, which also plays a role in 
activating CDK8 kinase activity. Compiling data from different studies, it has been 
shown that CDK8 kinase activity is activated through a series of sequential steps: the first 
is the binding of CDK8 to its cyclin partner, Cyclin C (CCNC), resulting in partial 
activation of CDK8.  This is then followed by the binding of MED12 which results in the 
final necessary conformational change30,31. Biochemical studies revealed that CCNC 
possesses a surface groove that acts as a MED12 docking site. Mutations in either CCNC 
or the MED12 interface located at the N-terminal of MED12 leads to the dissociation of 
CCNC-CDK8 from the core Mediator complex followed by impaired kinase activity of 
CDK832. These findings suggest that the MED12-CCNC binding interface serves as an 
anchor that also activates CCNC-CDK8. 
Kinase Module Paralogs 
Although highly conserved as a complete complex, the kinase module in 
vertebrates is unique and more complex when compared to the core complex as three of 
the four subunits have paralogs. CDK8 can be replaced by CDK19, MED12 can be 
replaced by MED12L, and MED13 can be replaced by MED13L33,34. The replacement of 
these subunits by their paralogs is mutually exclusive, meaning that the kinase module 
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can possess either MED12 or MED12L but not both subunits simultaneously, leading to 
eight different forms of the kinase module subunits (Figure 3)35. 
CDK19, the homolog of CDK8, shares a 91% sequence homology with CDK8.  
There is an especially high degree of sequence conservation in the kinase activity domain 
and cyclin binding domain, with more divergence in the C-terminal sequence. The high 
degree of similarity suggests that CDK8 and CDK19 have overlapping functions and that 
one may be able to compensate for loss or absence of the other as it relates to kinase 
activity. For example, isolation and purification of CDK8/CDK19 interacting proteins 
demonstrates that both CDK19 and CDK8 interact with PRMT5 during repression of 
transcription in HeLa cells (Tsutsui et al. 2013). However, given that the tail portion of 
CDK8/CDK19 interacts with transcription factors and cofactors, the difference in the C-
terminal sequence suggests that CDK8 and CDK19  more likely regulate different 
transcriptional programs33,36. Supporting this is the fact that CDK8 and CDK19 are 
differentially expressed across tissues, with CDK19 expression restricted to prostate, 
testis, thymus, and salivary glands, while CDK8 is expressed more ubiquitously across 
tissues37. 
Homology studies reveal that MED12 and MED12L share a 67% sequence 
identity, sharing two of four protein domains: PQL (proline/glutamine/leucine-rich) and 
OPA (C-terminal opposite paired domain). Interestingly, according to the human protein 
atlas, after analyzing approximately 37 human tissue samples, MED12L is found to be 
most highly expressed in the brain while MED12 is expressed ubiquitously in all 
tissues38,39 (for more information about the human protein atlas visit proteinatlas.org). 
Though they only share similarity in two of the domains, there does appear to be 
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functional redundancy between MED12 and MED12L. For example, a study by Vogl et 
al. suggests MED12 and MED12L have the same binding sites for SOX10, which is an 
essential component of the transcriptional network that regulates the development and 
terminal differentiation of myelinating glia. From a series of pull-down experiments of 
MED12/MED12L and SOX10 proteins, it is evident that the C-terminal region of both 
MED12 and MED12L interact with SOX10. This discovery lead to the assumption that 
both proteins have the same function in the regulation of transcription during the 
differentiation of myelinating glia40. However, there is currently little research in this 
area, making it difficult to evaluate the complete functional redundancy between MED12 
and MED12L. 
Finally, MED13L shares a 51% sequence similarity to MED1341 and they both 
serve to link the kinase module to core Mediator by associating with middle module 
subunits, MED14 and MED1942. Notably, this interaction of MED13/MED13L with core 
Mediator is regulated by SCF-FBW7 ubiquitin ligase through the proteasomal 
degradation of MED13/MED13L. Immunoprecipitation and in vitro ubiquitylation assays 
reveal that MED13/MED13L are directly ubiquitylated by SCF-FBW7 in vitro43. This 
degradation of MED13/MED13L prevents the kinase module from associating with the 
core complex suggesting that MED13/MED13L serves as an anchor for the kinase 
module. Interestingly, MED13L, but not MED13, associates with MED26, indicating 
there may be unique functions for each subunit. When co-purified, MED13L is 
accompanied by a high abundance of MED26; however, MED13L is not present in 
MED26 isolations. This association is found to be specific to MED13L, as the same set 
of pull-down assays does not show a robust association between MED13 and MED2642. 
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According to the human protein atlas, MED13L is primarily expressed in heart and brain 
while MED13 is expressed in all human tissues. More recent evidence supports previous 
studies indicating that mutations in med13l are associated with neurodevelopmental 
defects and heart diseases44,45. Knockdown and conditional knockout studies of MED13 
in murine zygotes suggest that MED13L can partially substitute for MED13 and function 
during the development of embryo46. This study demonstrates that MED13 is required for 
both transcriptional activation and repression during zygote genome activation, as 
demonstrated through the up- and downregulated transcripts observed in MED13-
knockdown embryos. Furthermore, med13 knockout embryos showed arrested 
development post-implantation. MED13L compensated for MED13 function during the 
OET (oocyte to embryo transition) enough to support embryo development to the 
blastocyst stage during preimplantation in med13 knockout murine zygotes. Clearly, the 
functional compensation of MED13 by MED13L is limited in context, as evident by its 
lack of compensation during post-implantation development and other studies showing 
mutations of MED13/MED13L that lead to disruptions of cellular functions resulting in 
respective disorders47,48. 
Together, studies surrounding the kinase module and each of the seven subunits 
indicate that the kinase module of the Mediator complex can present itself in many forms 
by changing its subunit configuration to diversify its function. Although it appears that 
there is some amount of functional overlap between paralogs, there is no complete 
functional redundancy for any of these kinase module subunits. Some of these paralogs 
may in fact play different roles in development and cell-type specific transcription 
programs. In addition, individual genetic mutations of kinase subunits leads to embryonic 
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lethality in mice and many human disorders with clear developmental 
disruptions26,46,49,50. In addition, research to date excludes the possibility of complete 
functional redundancy among the paralogs as they failed to substitute for their paralogous 
subunits (except for the partial functional compensation of MED13 by MED13L in 
murine zygote development as described in MED13 paralog section) when the other is 
genetically disrupted. The mutually exclusive nature, the unique expression profiles, and 
the relative functional contribution of each kinase module paralog still requires more 
thorough investigation to understand the structural interactions and functional 
relationships within the kinase module and what role each subunit plays in human 
development and disease. 
Kinase Module and Transcriptional Control 
The kinase module functions as both an activator and repressor of gene 
transcription, making the study of the module that much more complicated. Initial 
functional studies revealed a repressive function for the kinase module in S. cerevisiae 
where the Mediator core, together with the kinase module, repressed transcription and the 
Mediator core alone enhanced activator-dependent transcription51. Early electron 
microscopy and subsequent functional studies in human HeLa cells showed that the 
kinase module repressed transcription by preventing the binding of RNAP II to Mediator 
thereby blocking the formation of the PIC-scaffold complex. This inhibition was 
achieved via multiple mechanisms, including kinase-independent regulation of Mediator-
RNAP II interaction30, kinase-dependent inactivation of TFIIH by phosphorylation51, and 
gene silencing through the recruitment of histone methyl-transferases29. Later, 
biochemical and molecular studies supported the view that the kinase module has a 
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context dependent role in both gene repression and activation11,52. It now appears that 
when the Mediator core is absent, the kinase module acts to inhibit core Mediator 
function within the pre-initiation complex (PIC)29,52. Furthermore, the kinase module 
appears to mediate transcriptional activation through ncRNA-a (noncoding RNA-a, a 
class of ncRNAs which activate neighboring genes) by interacting with MED12 and 
chromatin53. Finally, a new role for the kinase module in the regulation of transcription 
elongation has been reported where the kinase module appears to coordinate with positive 
transcription elongation factor b (P-TEFb) by regulating its kinase activity. ChIP analysis 
and genome occupancy profiles of elongation factors in human cells indicate that CDK8 
orchestrates key events in the formation of a functional elongation complex. CDK8 is 
required for RNAP II dependent elongation by phosphorylating the C-terminal domain of 
RNAP II as they demonstrate that RNAP II elongation is impaired upon knockdown of 
CDK854. This study also suggests that the kinase module may facilitate the interaction of 
P-TEFb with core Mediator to regulate RNAP II phosphorylation and transcription 
elongation. These studies represent a marked advance in our understanding of how the 
kinase module acts to both repress and promote gene expression, while also revealing 
additional questions about the role the kinase module has as part of the core Mediator 
complex in regulating transcription. 
Although the precise mechanism that regulates the reversible association of the 
kinase module with core Mediator is not clearly understood, a few studies offer some 
insight into why the regulatory association of the kinase module with core Mediator 
occurs. Initial clues were provided by studies in yeast suggesting that the reversible 
association between the kinase module and core Mediator existed as way of regulating 
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the output of signaling-dependent transcription. Similarly, later studies in mammals 
suggest that specific cellular signals and signaling pathways regulate Mediator-kinase 
module association. For example,  an in vivo study by Mo et al. in human HeLa cells 
showed that in response to Ras signaling, the repressed promoter of the C/EBPβ is kinase 
module-bound whereas, upon activation, the kinase module is lost55. Another study by 
Pavri et al. demonstrated the switch from inactive to active Mediator executed by PARP-
1 during retinoic acid (RA)-induced gene expression in vivo. ChIP analysis of promoter 
occupancy in PARP-1 present and absent cells shows that in the absence of PARP-1, 
Mediator did not attain its active conformation (accompanied by loss of kinase module) 
upon RA induction as evidenced by the retention of CDK8 after RA treatment56. 
Although these studies do not prove the exact mechanism for what triggers the kinase 
module to dissociate from the core, they do suggest that the kinase-containing Mediator 
complex requires an interaction with other factors in order to detach from the kinase 
module and adopt the conformation required to facilitate transcriptional activation. 
Indeed,  Davis et al. demonstrated mechanistic evidence of kinase module dissociation 
involving SCF-FBW7 ubiquitin ligase mediated proteasomal degradation of 
MED13/MED13L, which anchors the kinase module to core Mediator43. A recent study 
by Youn et al. also demonstrated that the Mediator complex in mouse liver undergoes 
dynamic physiologic regulation through nutrient signaling-dependent downregulation of 
the kinase module to core Mediator. This dissociation and degradation of the kinase 
module is induced by SCF-FBW7 E3 ligase57. 
Finally, the Mediator kinase module has been implicated as a gene regulator in 
physiological processes from development and differentiation to the maintenance of cell 
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fate and function. Several genetic studies have revealed critical roles for kinase subunits 
in regulating signal-dependent gene expression during development49,58,59. In mice, 
kinase module subunits are found to be critical in early development, as evident by 
embryonic lethality resulting from mutations in kinase subunits. For example, embryo 
implantation failure is observed when CDK8 is inactivated through gene trap insertions, 
suggesting that CDK8 is necessary for preimplantation of mouse embryos50. CCNC 
knockout murine embryos failed to survive past implantation due to severe 
developmental retardation and an underdeveloped placental layer64. MED12 mutant and 
knockout embryos failed to survive later embryonic stages as they suffered from acute 
defects in developmental processes including neural tube closure and heart formation55. 
Several studies show that these developmental disruptions stem from defects in key 
developmental signaling pathways, including Wnt, Notch, mTORC1, and TGFβ. The 
kinase module subunits are found to be involved in expression of signaling pathway 
target genes and when mutated, lose their ability to activate or repress expression of 
required target genes for respective signaling pathways, leading to impaired responses of 
signaling pathways as illustrated by a growing number of developmental disorders. For 
example, loss of CDK8 in murine embryos is shown to disrupt Wnt target gene 
expression58. Mutant MED12 murine embryos showed aberrant Wnt/β-catenin target 
gene expression, indicating that MED12 is essential for Wnt signaling during 
embryogenesis where MED12 mutant embryos recapitulated phenotypes similar to those 
observed in the absence of β-catenin55. Recently, CDK8/CDK19 has been shown to have 
a role in negatively regulating Notch 1 signaling, a developmental pathway which 
regulates self-renewal and differentiation in several cell types including stem cells60. 
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Kinase subunits have also been linked to TGFβ, a developmental signaling pathway 
which regulates cell proliferation, differentiation, cell fate, and apoptosis. CDK8-CCNC 
plays a critical role in regulation of SMADS in TGFβ driven transcriptional responses by 
limiting the SMAD2/3-dependent induction of mesodermal cell fate in response to TGFβ 
signaling61. Recently, a study by Youn et al. demonstrated that when mice were fasted 
and refed, the kinase module dissociated and degraded upon nutrient activation of 
mTORC1 in mouse livers. This dissociation and degradation of the kinase module is 
necessary for the induction of lipogenic gene expression because 
genetic/pharmacological inhibition of mTORC1 in the fed state restores the kinase 
module suggesting that the kinase module plays a role in repressing lipogenic gene 
expression. In addition, genetically insulin resistant and obese mice in the fasted state 
showed elevated levels of lipogenic gene expression and loss of the kinase module was 
reversed following mTORC1 inhibition61. In agreement with these studies, the kinase 
module has been involved as the terminal factor of cell signaling pathways due to its 
representation as a final and functional target for transcription factors. Together, these 
studies imply a highly targeted role of individual Mediator subunits in the regulation of 
cell state and lineage commitment through the regulation of developmental signaling 
pathways. 
Kinase Activity 
Finally, one of the most important and highly conserved functions of the kinase 
module is its kinase activity. The best characterized of these activities is the kinase 
module’s phosphorylation of the C-terminal domain of RNAP II during transcription 
initiation, elongation, and RNA processing3. Human CDK8 appears to negatively 
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regulate transcription by phosphorylating TFIIH51, while inhibition of CDK8 kinase 
activity suppresses the RNAP II CTD phosphorylation thereby preventing elongation of 
transcription62. Despite the requirement for CDK8 and CCNC to interact and bring the 
kinase module together, the CDK8-CCNC interaction is not sufficient for CDK8 kinase 
activity. In the past two years, a series of studies by two different labs have provided 
evidence that MED12 is required for CDK8 kinase activity63,64. With a combination of 
Hi-C and cryo-EM studies along with knockdown studies in murine embryonic stem 
cells, MED12 knockdown cells showed acute depletion of Mediator and RNAP II, 
indicating that MED12 is required for proper phosphorylation of RNAP II. Another 
recent study by Klatt et al. described the binding location of MED12 and CDK8-CCNC 
dimer providing insight into activation of CDK8 by MED12. In vitro biochemical and in 
vivo studies together with cross-linking coupled with mass spectroscopy, demonstrated 
that the N-terminal of MED12 wraps around CDK8 at its T-loop to form an activation 
helix, which activates the enzymatic activity of CDK864. With MED12 now known to 
activate CDK8 as a kinase, the association of MED12 with the CDK8-CCNC dimer 
provides a critical element of regulation and prevents uncontrolled and inappropriate 
substrate targeting. 
Overall, the genetic and biochemical analysis of the kinase module is consistent 
with the functional studies indicating a role for this unique module in both gene 
activation and repression. The kinase activity of CDK8 is required for activator-
dependent transcription and has been shown to direct multiple steps in transcription 
including initiation, elongation, and re-initiation. Although several studies have begun to 
shed light on the signaling and mechanistic role for the kinase module and Mediator core, 
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there is still much to be explored. Involvement of kinase subunits in many physiological 
processes and pathways proves the complexity and the functional implications of the 
kinase module subunits either individually or as a complete structure. The significant 
functional involvement of the Mediator kinase module in regulating aspects of 
transcription has a significant impact on human development as illustrated by an 
increasing number of diseases and developmental disorders that have been associated 
Mediator subunit mutations (Table 1-1). 
1.2.2 The Kinase Module and Human Diseases 
The Mediator kinase module is a critical component of the transcriptional 
machinery required for proper regulation of gene expression and lineage commitment of 
cells during development and tissue differentiation1,6,8. Kinase module subunits, as part of 
the Mediator complex, have been linked to many key developmental and oncogenic 
signaling pathways including Wnt, mTORC1, EGF, SHH, and Notch10,49,65,66. Alterations 
of individual subunits of the kinase module have been associated with developmental 
defects and diseases including Lujan syndrome, schizophrenia, breast and uterine 
cancers, and cardiovascular diseases67. Studies have found that the kinase module 
subunits are direct targets of genetic alteration in human tumors and specifically, 
MED12, the largest subunit of the kinase module, has been consistently implicated in 
many female cancers and cognitive developmental conditions. Research indicates that it 
is the role of MED12 in regulating the kinase activity of the module that leads to a 
number of these outcomes68. Specific roles for each of the kinase module subunits in 
development and disease can be found in Table 1-1. 
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Table 1-1: Currently known roles for Mediator kinase subunits in development or 
disease. Most cancers noted in this table were previously compiled and reviewed by 
Clark, Oldenbroek, & Boyer69. 
Subunit Role 
CCNC  Multiple deletions associated with T-cell acute lymphoblastic leukemia; 
function as a tumor suppressor60,70 
 
Deletion associated with osteosarcoma; function as an inhibitor of cell 
growth71 
 
Regulation of adipogenesis72 
 
G0 to G1 transition in CD34
+ cord blood cells73 
CDK8 Phosphorylation of TFIIH to activate transcription51 
 
Phosphorylation of E2F to activate transcription74 
 
Phosphorylation of RNA Pol II C-terminal domain to repress 
transcription75,76 
 
Maintenance of ESC pluripotency mediated by MYC protein77 
 






Endometrial cancer tumor suppression82 
 
Alzheimer’s disease83 





MED12 Designated a cancer driver gene86,87 
 
Uterine leiomyoma oncogenesis68,88,97–101,89–96 
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Breast fibroadenoma oncogenesis and phyllodes tumorigenesis102–107 
 
Prostate cancer oncogenesis108–110 
 
Interaction with NANOG and SOX2 C-terminals to regulate ESC 
pluripotency111 
 
Interaction with Wnt/β-catenin to recruit core Mediator to target genes49 
 





Maintenance of HSC viability26 
 
Neural development in zebrafish113–115 
 
Interaction with SOX10 in myelinating glia40 
 







MED12L Designated a cancer driver gene120 
 
Interaction with SOX10 in myelinating glia40 
MED13 Neurodevelopmental disease121 
 
Breast cancer oncogenesis122 
 
Regulation of early embryogenesis46 
 
Interaction with Smad7 to regulate myogenesis123 






1.2.3 The Kinase Module and Stem Cells 
All cells in an adult human have the same 3 billion base pair genome, but it is 
how that genome is expressed that determines whether a cell becomes a myocyte, an 
osteocyte, a neuron, etc. Stem cells are both able to clone themselves and able to become 
specialized cell types by pursuing one of a number of possible cellular lineages. 
Pluripotent stem cells, such as embryonic stem cells in the blastocyst stage of embryonic 
development, are ultimately committed to cells of either the endoderm, mesoderm, or 
ectoderm lineage4. Gene regulation is tightly controlled in order to ensure proper 
transcription for healthy organismal development. Aberrant gene expression is implicated 
in a multitude of developmental defects and disease and would be more rampant if not for 
the highly specialized, complex method for cell type-specific transcriptional control125,126. 
The unique properties of stem cells to both self-renew and differentiate under controlled 
laboratory conditions allows for the effects and functional characterization of deliberate 
perturbations in the regulation of gene expression4. This includes altering the function 
and expression of the general transcription factors (GTFs) that assemble the transcription 
pre-initiation complex on gene promoters, activators and repressors that bind to gene 
regulatory elements located upstream or downstream of promoters, and the essential co-
activator of cell type-specific genes like the Mediator complex. The fate of any stem cell 
is ultimately determined by regulating the transcription of specific genes, a feature 
largely facilitated by the Mediator complex. 
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Stem cells are categorized based on their differentiation potential. Totipotent stem 
cells have the potential to become any cell type in the body including extraembryonic 
tissue; an example of which is the zygote4,127. Pluripotent stem cells, such as embryonic 
stem cells in the blastocyst stage of embryonic development, are committed to cells of 
either the endoderm, mesoderm, or ectoderm lineage128. Adult stem cells are a 
multipotent cell type that can be found in umbilical cord blood and tissue, bone marrow, 
adipose tissue, and several other fully developed organs129,130. These cells have a more 
restricted developmental pathway and, in the body, will only become cells of that tissue 
or organ. Of course, the potential for stem cells to differentiate allows them to change 
their transcription program in response to the environment. In this way, a stem cell is a 
progenitor possessing a certain identity, and by changing its transcription program, it can 
assume a new identity as a differentiated somatic cell. Despite different levels of 
differentiation potential possessed by different classes of stem cells, all stem cells share 
the ability to self-renew4. We will begin this section by exploring stem cell self-renewal 
and the role of the Mediator complex kinase module in this process, followed by the 
kinase module’s regulation of differentiation down the various possible lineages. 
Kinase Module and Self-Renewal 
Self-renewal is the process by which stem cells replicate themselves to maintain a 
stable population of undifferentiated clones. For individual stem cells, self-renewal and 
differentiation are mutually exclusive in that lineage commitment down a differentiation 
pathway alters a stem cell’s gene expression profile away from self-renewal permanently. 
If a stem cell is not self-renewing, it is differentiating, and vice versa131—until the stem 
cell reaches quiescence, temporarily halting further self-renewal132. 
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Work by Miyata et al. revealed that, when exposed to cytokines, human cord 
blood CD34+ cells in the quiescent G0 phase of the cell cycle expressed CCNC at a higher 
level compared to cells in the more growth oriented G1 phase. This led them to perform 
an shRNA-mediated knockdown of CCNC in the cord blood cells which resulted in an 
increase in G0 cells in their culture population as determined by Hoechst and Pyronin Y 
staining. It must be noted that the knockdown of CCNC did not increase differentiation. 
Interestingly, in the absence of CCNC, cord blood cells were able to maintain expression 
of CD34 at higher levels than control cells through up to 4 weeks of cell culture, possibly 
due to the induced quiescence keeping the cells in a protracted immature state73. 
Like CCNC, CDK8 has also been shown to play a role in stem cell self-renewal. 
Murine ESCs showed a significant reduction in both transcript and protein expression of 
CDK8 post-differentiation. Following this, an shRNA knockdown of CDK8 was 
performed in murine ESCs which resulted in a loss of ESC pluripotency. This was 
determined by the reduced expression of NANOG and OCT4, reduced alkaline 
phosphatase staining, and reduced colony formation in these cells. Further study revealed 
that CDK8’s regulation of pluripotency was at least partially mediated by MYC protein77. 
Co-IPs were used to determine the interaction between MED12 and the C-
terminal domains of NANOG and SOX2 in ESCs. Furthermore, an siRNA-mediated 
knockdown of MED12 was performed in murine ESCs. NANOG transcript and protein 
levels fell by as much as 65% in the absence of MED12 in addition to the onset of 
spontaneous differentiation. This loss of pluripotency during MED12 knockdown could 
not be rescued by a NANOG-expressing doxycycline system, indicating the requirement 
for MED12 for proper differentiation. In ESCs undergoing differentiation, while the 
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expression of NANOG, OCT4, and SOX2 decreased, MED12 expression increased 3.5-
fold. NANOG and MED12 co-occupy NANOG target genes during pluripotency, but this 
co-occupancy ends during differentiation111. This work was later challenged by data 
collected in a recombinant murine ES cell line expressing a hypomorphic MED12 mRNA 
at low levels. Despite this, the absence of MED12 was embryonic lethal in mice, and this 
was attributed to MED12’s interaction with Wnt/β-catenin signaling pathway for 
recruiting core Mediator to target genes49. 
ChIP-seq analysis conducted in murine ESCs revealed a small degree of 
overlapping genome occupancy between CDK8, MED12, and the polycomb repressor 
complex 1 (PRC1) subunit RING1B. PRC proteins are known regulators of embryonic 
stem cell state. Of the identified MED12 targets, 21% were co-occupied by RING1B. 
Furthermore, 80% of these regions occupied by MED12 and RING1B were also occupied 
by MED1, indicating that the entire core Mediator was present at these sites. Gene 
ontology identified these sites as genes necessary for differentiation and development. An 
shRNA-mediated knockdown of RING1B in murine ESCs saw a marked decrease in 
MED12 chromatin interaction. The inverse was not true in a MED12 knockdown 
condition where MED12 recruitment to core Mediator was reduced in the absence of 
RING1B, and Co-IP confirmed that MED12 and RING1B interact directly. Quantitative 
PCR found that, in pluripotent murine ESCs, almost 600 genes were more highly 
expressed in the absence of either MED12 or RING1B, showing a role for MED12 and 
RING1B in development-associated gene repression during pluripotency; however, 
further research indicated that MED12—not RING1B—was responsible for activating 
development genes during murine ESC differentiation112. 
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As discussed previously, MED12 is critical for maintaining HSC viability. After 
performing MED12 knockouts in mice using a Cre recombinase system, a 75% decrease 
in cell numbers was observed in the bone marrow and thymus of the MED12 knockout 
mice compared to a control. A CFU assay revealed that HSCs lacking MED12 were 
unable to form colonies, highlighting a failure in HSC self-renewal. Interestingly, the 
researchers knocked out MED12 in an immortalized mouse embryonic fibroblast (MEF) 
cell line and observed no significant changes in cell growth compared to a control. A 
similar experiment in murine ESCs were able to maintain pluripotency markers and self-
renewal capability despite the absence of MED1226. These findings suggest that, although 
different stem cells have similar properties such as self-renewal and differentiation, 
potency and lineage commitment of different stem cell classes is governed by highly 
specific regulators. 
Finally, zygotes and other totipotent stem cells also offer an opportunity to 
broaden our understanding of self-renewal. Microarray analysis revealed that, out of all 
Mediator subunits, MED13 was the most highly translated Mediator subunit during 
oocyte maturation with MED13L and MED12L ranking at second and third, respectively. 
This high level of MED13 translation continues into the two-cell (2C) stage of embryo 
development. Morpholino oligonucleotides were used to block MED13 translation at the 
single-cell zygote stage 4 hours post-fertilization, and while the zygotes underwent 
cleavage into the 2C stage, only 40% of tested embryos were able to advance to the 4C 
stage. Those embryos that reached 4C halted thereafter. Performing the same experiment 
6 hours after fertilization allowed 78% to advance to the morula stage. After ruling out 
transcription and DNA replication failures as reasons for the MED13 knockdown’s 
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effects, RNA-seq analysis revealed 1201 upregulated and 2203 downregulated genes in 
the absence of MED13. RNA processing, cell cycle, transcription, protein catabolism, 
and chromatin modification were among the categories of the downregulated genes 
discovered during GO analysis46. Given that these sets of genes are important for 
determining cell state, these results point toward the Mediator kinase module as an 
integral cell state regulator. 
Kinase Module and Differentiation 
Differentiation is the process by which a stem cell alters its transcription program 
in response to the external environment and internal regulation to commit to one of its 
many potential lineages. In normal, healthy stem cells, differentiation is a permanent 
epigenetic transformation that, once started, causes a stem cell to lose its potency and 
self-renewal capacity while gaining specialized forms and functions important to the 
operation of tissues and organs. Here we review some of the lineage commitments where 
the kinase module has been shown to play a significant role to further support the critical 
role of Mediator in directing cell fate and need for continued research in this area. 
Adipogenesis: 
Work by Song et al. involved screening adipocytes with shRNA libraries to 
identify genes whose expression was altered during adipogenesis. CCNC and CDK19 
were found to be downregulated while CDK8 was upregulated during adipogenesis. 
CCNC and CDK19 expression in brown adipose tissue of 2-year-old mice was down to 
25% of the expression levels present in 3-month-old mice. Conversely, CDK8 expression 
was twice as high in the brown adipose tissue of older mice when compared to the 
younger mice. Since brown adipose tissue is responsible for producing heat, groups of 
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mice were exposed to either 4°C or 22°C conditions. The transcription levels of ccnc, 
cdk8, and cdk19 mRNA were determined to be unaffected by these differences in 
temperature; however, CCNC and CDK19 protein expression fell slightly while CDK8 
rose in the 4°C group compared to 22°C. After performing siRNA knockdown of ccnc, 
the expression of adipogenesis markers including PPARG, FABP4, and CEBPA fell 
during the first 2 days of adipogenesis, but expression of these genes increased after 5 
days to the levels in the control group. After switching to an inducible knockout system 
for CCNC, cells undergoing CCNC knockout did not undergo adipogenesis and did not 
express the previously tested adipogenic markers as well as a host of other genes 
associated with brown adipose tissue, mitochondria, and lipogenesis. Retroviruses 
expressing CCNC only partly rescued adipogenesis in CCNC knockout cells but did not 
improve adipogenesis in cells unaffected by CCNC knockout. The most down regulated 
pathway in the absence of CCNC was the PPAR pathway, a master regulator of 
adipogenesis. PPARG-2 overexpression rescued both lipid vesicle formation and 
adipogenic marker expression in CCNC knockout cells, showing that PPARG’s activity 
does not depend on CCNC. C/EBPα, a co-regulator of adipogenesis along with PPARG, 
could not rescue adipogenesis upon overexpression in CCNC knockout cells. Due to 
C/EBPα being an important regulator of white adipose tissue, siRNA knockdown of 
CCNC was also performed in 3T3-L1 cells, revealing a similar decrease in lipid 
accumulation and adipogenic marker expression as was seen in brown adipose tissue72. In 
summary, CCNC regulates adipogenesis by interacting with C/EBPα. 
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Myogenesis: 
Like adipogenesis, the process of differentiating into skeletal muscle tissue 
involves interactions between kinase module subunits and transcription factors to achieve 
proper regulation. MED12 and β-catenin are known to interact133, and β-catenin is active 
during myogenesis134–136. Further research found that not only does Smad7 interact with 
β-catenin to regulate myogenesis, but Smad7 also interacts directly with MED13. The 
significance of this finding is that the Smad7:β-catenin complex could be responsible for 
recruiting core Mediator to myogenesis-specific promoters via kinase module association 
through MED12 and MED13123. 
Osteogenesis: 
Bone tissue is maintained by the actions of osteoblasts and osteoclasts. 
Osteoblasts perform mineralization that increases bone density whereas osteoclasts resorb 
bone matrix which decreases bone density. Initial research revealed that the inhibition of 
CDK8/19 could interfere with the self-renewal capacity of bone progenitor stem cells by 
virtue of the Wnt signaling pathway. Though bone formation was disrupted by CDK8/19 
inhibition, it was through a mechanism independent of Wnt137. Later work tested the 
effects of CDK8/19 inhibition on murine bone marrow macrophages, osteoblasts, and 
osteoclasts. While inhibition did not affect macrophage and osteoblast self-renewal, it did 
reduce the osteoclast differentiation of the macrophages and lead to significantly 
decreased bone matrix resorption. Both effects were reversed by withdrawing the 
CDK8/19 inhibitors. Expression of osteoclastogenic genes were downregulated in 
macrophages exposed to CDK8/19 inhibition. Meanwhile, CDK8/19 inhibition increased 
ALP activity in murine osteoblasts and boosted calcium deposition138. This research 
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demonstrates CDK8 and 19’s role in maintaining bone tissue by playing on the side of 
osteoblast and osteoclast activity simultaneously. It is possible that all the kinase module 
subunits are responsible for acting as both drivers and repressors to a certain degree, 
especially given their relationships to oncogenesis. 
Neurogenesis: 
Due to the difficulty of studying mammalian neurogenesis directly, murine or 
human stem cells and tissue, along with zebrafish models represent the primary means of 
exploring this area of development and differentiation116. Research in this area began by 
identifying mutations of MED12 (at that time referred to as TRAP230, or thyroid 
hormone receptor-associated protein) that produced truncated MED12 protein, resulting 
in zebrafish brain tissue that developed all the correct regions but failed to expand 
anteriorly and posteriorly while also failing to form the forebrain and midbrain 
ventricles113. Another mutation of MED12 was found to disrupt neural tissue 
development in zebrafish, and the mutant embryos were rescued by the introduction of 
wildtype med12 mRNA. In situ hybridization was used to determine that MED12 is most 
active in the part of the zebrafish brain forming the ventricle lining. Overexpression of 
MED12 lead to premature neuronal development and increased differentiation of 
monoaminergic neurons but did not increase neuron differentiation overall114. MED12 
was later found to interact with the intracellular domain of amyloid precursor protein 
(AICD), a protein essential for brain development and function115. MED12 coactivates 
tbx2b transcription which guides neural progenitor cells toward correct epithalamic 
differentiation at a critical moment in brain development in zebrafish116. Beyond neurons, 
MED12 and MED12L were also discovered to interact with SOX10 in order to direct the 
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development of Schwann cells and oligodendrocytes, two types of glial cells that are 
responsible for the formation of myelin sheaths that insulate neuron axons and accelerate 
action potentials40. 
1.3 Significance of Understanding Mediator’s Kinase Module 
Nearly thirty years ago, a question about in vitro gene activation led to the 
discovery of the Mediator complex. At once, this expanded our understanding of how 
complex life can be achieved with relatively few genes. Since then, each answered 
question has bred a multitude of further questions. Because of that, we now know how 
near (or far) gene regulatory elements are from gene promotors, how Mediator reaches 
across vast linear distances through the three-dimensional folding of chromatin to reach 
those elements, and that super-enhancers work with Mediator to regulate cell type-
specific gene transcription. The kinase module has expanded the complexity of this 
regulatory relationship given its transient nature, and we are certain of the kinase 
module’s subunit and paralog composition with CDK8/19 possessing kinase activity. It is 
understood that each kinase module subunit plays an integral role in the module’s overall 
stability, thereby enhancing its regulatory and kinase activity. Unfortunately, mutations in 
these subunits have been implicated in a host of developmental disorders and diseases, 
including many cancers. wherein lies the importance of proper kinase module functioning 
to maintain healthy development and cell fate determination. Research is now branching 
into the kinase module’s activity in the context of stem cell self-renewal and 
differentiation. 
Despite what we have learned, we still do not have a complete understanding of 
how, precisely, the kinase module interacts with nuclear machinery and signaling 
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molecules to drive cell state into a particular direction: either to maintain homeostasis or 
to differentiate down the epigenetic landscape toward any particular lineage while 
avoiding oncogenesis. Though we know several targets of kinase module interaction in 
this context, we are far from knowing them all. A large focus has been placed on MED12 
(warranted considering its importance in oncogenesis and development), and this has 
elevated the profile of the individual subunit and that of the entire kinase module. While 
this is bearing good fruit in terms of thorough research (ChIP-seq and genome-
interactions), more abundant fruit would be reaped by similarly thorough elucidation of 
the other subunits and their interactions with each other. It must be stressed that there is 
much about the paralogs (MED12L, MED13L, CDK19) that we have yet to explore. 
What regulatory advantages do the paralogs offer the kinase module? How much 
functional overlap is there between the paralogs, and what is the relative expression 
between them? Does their expression change depending on cell state, and how would 
their relative expression levels affect cell state? And then, there is the added dimension of 
cell signaling factors that may or may not influence Mediator and its kinase module, or 
vice versa. 
The great web of interactions between Mediator, the kinase module, the various 
transcription factors, and the multitude of signaling molecules is falling into place piece-
by-piece, but work is far from finished. The benefits of this knowledge extend beyond 
molecular biology, stem cell biology, and biochemistry and into the realm of clinical 
application. Given a more complete map of cell state regulation, we may one day see the 
efforts of this research pay off in the form of regenerative medicine involving stem cell 
therapies that are tailorable to individual patients, therefore maximizing patient benefit 
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and minimizing patient harm. We may discover ways to manipulate stem cells that we 
previously could have only imagined, and then we’ll have uncovered the elusive fountain 
of youth. These possibilities are beyond our grasp now, but no great height was ever 
reached without a solid foundation, and it is this foundation that current research must 
continue to build. 
Ultimately, the study of Mediator and its kinase module will necessitate increased 
collaboration between the fields of stem cell biology, cell signaling, and transcriptomics. 
That level of research is a difficult undertaking given the shear complexity of gene 
expression regulation. One of the joys of biology is that despite how complex it all may 
seem, there is a hidden elegance to all the intertwined systems that make cells and 
organisms function, and function well. Unfortunately, the nature of foundational research 
tends to render an individual researcher unable to see the forest for the trees, but as 








THE ROLE OF MED31 IN ADIPOGENESIS 
 
This work was previously published in Molecular Biology Reports, titled “MED31 
involved in regulating self-renewal and adipogenesis of human mesenchymal stem cells.” 
Permission to reuse this work in this dissertation is granted by Springer Nature under 
their Author Reuse Policy. Full citation: Beadle, E. P., Straub, J. A., Bunnell, B. A. & 
Newman, J. J. MED31 involved in regulating self-renewal and adipogenesis of human 
mesenchymal stem cells. Mol. Biol. Rep. 45, 1545–1550 (2018). 
2.1 Background 
Mesenchymal stem cells (MSCs) are multipotent, adult stem cells derived from 
both adipose tissue (ASCs) and bone mar- row (bMSCs)139. MSCs retain the capacity to 
be naturally differentiated into osteoblasts, adipocytes, chondrocytes, stromal cells, and 
myoblasts. This differentiation capacity allows for many potential cellular therapies to 
repair damage in bones, tendons, and muscles. MSCs also have immunomodulatory 
properties that allow them to seek out sites of inflammation in the body and, upon arrival 
to their destination, secrete regulatory cytokine and chemokine factors to suppress 
inflammation which has been shown to delay graft rejection and treat some autoimmune 
disease5,140,141. 
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The Mediator complex is a transcriptional coactivator with the capacity to loop 
double stranded DNA and coordinate transcriptional activation and repression in a cell-
type specific manner. During the looping process, enhancer elements and their bound 
transcription factors are folded closer to the promoter region of the gene. As the DNA is 
looped by Mediator, an elaborate network of protein–protein interactions is formed 
between general transcription factors, RNA Polymerase II, Mediator, and cell type 
specific transcription factors bound at enhancer elements. Weighing approximately 1.5 
megadaltons, Mediator is a multi-module complex that is comprised of approximately 30 
subunits organized into four different sub-modules and is conserved across the eukaryotic 
domain from yeast to humans142. 
Individual Mediator subunits can form protein–protein interactions with different 
key regulators of cell state, showing the importance for Mediator in the proper regulation 
of cell state and development. For example, loss of MED1 and MED12 in mouse 
embryonic stem cells causes spontaneous differentiation suggesting a regulatory role for 
MED1 and MED12 in the pluripotency of ESCs14. MED1 and MED12 have been shown 
to be required for proper hematopoietic stem cell population maintenance143 and proper 
cardiac development144, and MED12 is essential for neuronal development in many 
different organisms including zebrafish114, mice40, and even humans117–119,145,146. 
MED31 is one of the most conserved subunits of the Mediator complex; however, 
it is also one of the least characterized with regards to its biological function in 
multicellular organisms. MED31 is an integral part of the Mediator complex displaying a 
variety of functions in several model organisms and cell lines. MED31 has recently been 
identified as a binding target for TREX-2, a protein involved in both transcription and the 
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export of mRNA out of the nucleus through the nuclear pore complex. In the absence of 
MED31, TREX-2 is unable to bind to Mediator thereby inhibiting the formation of the 
pre-elongation complex for mRNA synthesis and RNA Pol II phosphorylation147. 
MED31 acts as a protein bridge within the Mediator complex connecting both the head 
and middle modules, and when labelled or deleted its structural interactions can be 
disrupted. This structural disruption ultimately results in abolished protein interactions 
thus modifying transcription in a very specific manner9. 
MED31’s role in mammalian development was first characterized in 2010 when 
Risley et al. identified a mouse MED31 mutant that displayed late gestation lethality and 
significant growth defects such as decreased cell proliferation in mouse embryonic 
fibroblasts (MEFs) and limb buds, smaller bone structures, and decreased expression of 
the essential developmental genes Sox9, Col2A1, mTOR, and cyclin B148. In 2013, 
Schiano et al. found that MED31, along with MED1 and MED20, were significantly 
upregulated in three osteosarcoma cell lines compared to osteoblasts149. In addition, Jiang 
et al. in 2014 found that MED1 and MED31 were consistently overexpressed in 
osteosarcoma and that inhibition of either reduced both cell proliferation and cell cycle 
progression. Further investigation during this study suggested that MET signaling and 
ERK 1/2 phosphorylation were reduced, possibly explaining this phenotype. Taken 
together, these results suggest that MED31 plays a role in cell proliferation and cell cycle 
progression in osteosarcoma cells possibly through MET signaling or the ERK 1/2 
signaling cascade150. The role of MED31 in normal cell state maintenance and directed 
differentiation remains uncertain. Given existing evidence for a role of MED31 in 
osteogenesis, we were interested in looking at adipogenesis, a process often considered 
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opposing to osteogenesis. Here we show that the loss of MED31 is not lethal to hMSCs 
but does impact the rate of proliferation and impedes adipogenesis, suggesting a critical 
role for MED31 in hMSC fate. 
2.2 Methods 
2.2.1 Cell Culture 
Human bone marrow-derived mesenchymal stem cells (hMSCs) were maintained 
in MEM-α containing 16.9% fetal bovine serum, 1% Penicillin and Streptomycin, and 
1% l-Glutamine. Cells were cultured in a humidified incubator at 37 °C and 5% CO2. 
The 5062L donor cells were isolated from a normal, healthy donor and were 
characterized and provided by Dr. Bruce Bunnell and his lab at Tulane University School 
of Medicine. The cell line used had no further donor information disclosed to prevent 
data biases. For in vitro adipocyte differentiation assays the cells were cultured in 
AdipoQual™ Medium (LaCell: LaADM-500) for the duration of the differentiation 
protocol. After reaching the terminal time point, the cells were fixed in formalin and 
stained with Oil Red O. Levels of adipogenic differentiation were quantified by 
extracting Oil Red O stain using isopropanol and read at 544 nm. Stain extractions were 
normalized against the protein content of the samples collected using RIPA buffer and 
quantified using Bradford assays. Assays were performed in biological triplicates. 
Statistical analysis was performed using unpaired, two-tailed t-tests. 
2.2.2 Transient Transfections and Small Interfering RNAs 
HMSCs were seeded at approximately 40% confluence and transfected 24 h later 
with 10 µM stock concentrations of Med31 siRNA (Thermo Fisher; 4392420) or a 
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scrambled siRNA negative control (Thermo Fisher; 4390843) using Lipofectamine 
RNAimax (Invitrogen) following the manufacturer’s protocol. 
2.2.3 RNA Extraction, cDNA Synthesis, and qRT-PCR 
Total RNA was extracted using TRIZOL reagent (Invitrogen) following the 
manufacturer’s protocol. For microarray analysis, total RNA was extracted using 
RNeasy® Mini Kits (Qiagen) following the manufacturer’s protocol. cDNA was 
synthesized using qScript™ cDNA SuperMix (Quanta Biosciences) following the 
manufacturer’s protocol. Quantitative reverse transcription-PCR (qRT-PCR) was used to 
quantify transcript expression levels for med31, adiponectin, and srebp-1c. qRT-PCR 
was performed using PowerUp™ SYBR© green master mix as designated by the 
manufacturer’s protocol on the Applied Biosystems StepOnePlus™ qRT-PCR System. 
Gene expression levels were normalized to gapdh using CT values. Fold changes and 
relative remaining transcript were calculated using the 2−𝛥𝛥𝐶T method. Results were 
reported as an average of three or more biological replicates with error bars denoting the 
standard error of the mean (SEM). 
2.2.4 Western Blotting 
HMSCs were seeded at 3 × 105 cells per 10 cm dish and cultured overnight. Upon 
reaching terminal time point post transfection with Lipofectamine® RNAiMAX, the cells 
were washed twice with PBS and harvested on ice using 400 µL RIPA lysis buffer 
(Abcam) supplemented with a Pierce™ EDTA-Free Protease Inhibitor Mini Tablet 
(Thermo). Whole cell lysates were agitated for 30 min at 4 °C and then centrifuged for 20 
min at 12,000 RPM at 4 °C. Protein samples were quantified using BSA standard curves 
generated using Bradford assays. SDS-PAGE was performed using a Mini- PROTEAN® 
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TGX™ (Bio-Rad) gel and a standard protocol. Proteins were transferred onto a Trans-
Blot® Turbo™ Transfer Pack 0.2 µm PVDF membrane (Bio-Rad) using a Trans-Blot® 
Turbo™ transfer system (Bio-Rad) and the manufacturer’s protocol. After transfer, 
membranes were cut into designated pieces and blocked for 2 h in 5% milk in 1× TBS 
with 0.1% Tween®-20. The membrane was probed overnight with primary antibody 
(1:100 for MED31; 1:3000 for GAPDH), washed 5 times, and probed with secondary 
antibody (1:1000). Blots were developed using ECL and chemiluminescence. The 
primary antibodies used were obtained from Santa Cruz Biotechnology (sc-101189) and 
Abcam (ab9485) for MED31 and GAPDH, respectively. 
2.2.5 AlamarBlue Cell Proliferation Assay 
HMSCs were seeded at 4000 cells per well on 24 well tissue culture treated 
plates. The hMSCs were transfected 24 h post seeding and allowed to incubate for 
another 24 h following transfection. After 24 h, the alamarBlue assay was performed as 
instructed by the manufacturer’s protocol. Fluorescence readings were recorded at 
560/590 nm on a Cytation™ 5 plate reader (BioTek). 
2.2.6 Live/dead Assay 
A cell viability assay was performed using ReadyProbes® Cell Viability Imaging 
Kit (Life Technologies) following the manufacturer’s protocol for untreated, negative 
control, and MED31 knockdown cells. Images were taken on the EVOS FL imaging 
system and analyzed using ImageJ software. The counted nuclei of both dead (red) and 
live cells (blue) were averaged for six biological replicates and a t-test was used to 
calculate significance. 
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2.2.7 Microarray and GO Analysis 
RNeasy® mini kits (Qiagen) were used to extract total RNA from hMSCs treated 
with a negative control siRNA or a Med31 siRNA after 72 h post transfection. Full 
transcriptome array hybridization was performed using GeneChip™ Human Genome 
U133 Plus 2.0 Arrays (Affymetrix) at Louisiana Health Sciences Center-Shreveport. Data 
analysis was performed using Affymetrix™ software to determine fold change of 
knockdown compared to control samples. The DAVID bioinformatics database, version 
6.8, was used to perform gene ontology (GO) analysis for the significantly different 
genes151. The functional annotation clustering tool was used to retrieve GO terms 
corresponding to the biological process, molecular function, or cellular compartment of 
each differentially regulated gene. Histone clusters were differentially regulated and 
created a high volume of GO terms regarding DNA condensation and transcriptional 
regulation. Histone clusters were excluded for a secondary analysis to evaluate the other 
differentially expressed genes as a response to MED31 knockdown. 
2.2.8 Statistical Analysis 
Statistical analysis was performed using a Student’s two tailed t-test when 
appropriate. ANOVAs were used to establish significance for the microarray data and for 
any other assays where appropriate.  
2.3 Results 
2.3.1 MED31 Knockdown Does Not Affect hMSC Viability 
MED31 is an integral part of the Mediator complex located in the middle module 
of the complex (Figure 2-1). To determine the functional role of MED31 in 
mesenchymal stem cells, an siRNA-mediated transfection was used to knock down 
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MED31. Knockdowns were allowed to incubate and demonstrated a significant decrease 
in MED31 transcript up to 5 days (Figure 2-2) and a significant reduction in protein at 4 
days or 96 h (Figure 2-3). To assess the initial effects of a MED31 knockdown on self-
renewal, alamarBlue assays and cell counting were performed on multipotent hMSCs. 
The alamarBlue assay demonstrated a decrease in the proliferative rate of MSCs 
suggesting some impact on cell state following MED31 knockdown (Figure 2-4). This 
was complimented with a cell count experiment that demonstrated no significant 
difference in cell number over time between MED31 knockdown and negative control 
knockdown cells (Figure 2-5). However, a difference was observed between the negative 
control and untreated cells indicating some impact of transfection on cell viability. 
 





Figure 2-2: med31 transcript remaining following MED31 knockdown in 
undifferentiated hMSCs at 48 h, 72 h, and 5 days post-transfection. All data points 
represent the average of three biological replicates and data is normalized to gapdh for 













Figure 2-3: MED31 protein remaining (top) and protein quantification via ImageJ 
analysis (bottom) following MED31 knockdown. Western blot represents whole cell 
lysates of undifferentiated cells collected 96 h post-transfection. All data points 
represent the average of three biological replicates and data is normalized to GAPDH 





Figure 2-4: AlamarBlue cell assay. P < 0.05 between negative and MED31 





Figure 2-5: Cell counting experiment quantifying viable cells following MED31 
knockdown confirming an impact of transfection but no difference in viable cell 
number between control and MED31 knockdown samples. 
* 
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2.3.2 MED31 Required for Maintenance of Self-Renewing State 
To determine if the slowed proliferation might be the result of spontaneous 
differentiation that could be assessed by changes in gene expression, microarray analysis 
was performed. Microarray analysis further indicated a decrease in self-renewal 
capabilities 72 h after knockdown of MED31 (Figure 2-6). Microarray analysis of 
biological triplicate experiments demonstrated a significant (threefold) decrease in med31 
transcript, validating knockdown. In addition, of the 105 genes that showed a greater than 
twofold decrease in gene expression, gene ontology suggests a majority of these genes 
are associated with cell replication. This includes transcripts for genes involved in 
telomere organization and DNA replication. Some genes, including flg appear more than 
once, indicating probes for different transcripts, while simultaneously confirming a 
significant change in expression of those genes. Finally, of the 18 genes that 
demonstrated a greater than twofold increase in expression, gene ontology terms 
highlighted the extracellular compartment, plasma membrane, and cell–cell signaling, 
while also reporting female pregnancy genes as upregulated in response to MED31 
knockdown. 
 
Figure 2-6: Heat map represents genes of greatest fold change resulting from MED31 
knockdown determined by microarray analysis. Asterisks indicate genes of interest 
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with * representing genes involved in cell cycle and self-renewal and ** representing 
genes involved in development and differentiation. 
2.3.3 MED31 Regulates Adipocyte Differentiation 
HMSCs have the ability to differentiate down the mesodermal lineage and are 
easily differentiated in the lab into adipocytes and osteoblasts. Here, adipocyte 
differentiation was induced for 7 days following an siRNA-mediated MED31 
knockdown. A single transfection was performed 24 h before initiating differentiation. 
Transcript and protein levels confirm a significant knockdown up to 7 days post 
transfection (Figure 2-7; Figure 2-8) providing support for the observed phenotype. 
Morphology, along with Oil Red O staining (Figure 2-9), demonstrate a visible decrease 
in adipocyte differentiation following the loss of MED31. Finally, qRT-PCR of genes 
indicative of adipocyte differentiation, srebp-1c and adiponectin, demonstrate a 
significant decrease in transcript levels for each of these genes 7 days into differentiation, 
further confirming the phenotypic results (Figure 2-10). This observed decrease in 
adipocyte differentiation following the loss of MED31 suggests that MED31 has a role in 
regulating adipogenesis by potentially activating genes responsible for adipocyte 
differentiation of hMSCs. Proper moderation and regulation of differentiation is critical 
for healthy development and MED31 appears to be an important feature of 
developmental control (Figure 2-11). 
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Figure 2-7: med31 transcript remaining following MED31 knockdown in adipogenic-
differentiated hMSCs at 7 days post-transfection. All data points represent the average 
of three biological replicates and data is normalized to gapdh for each sample. Error 










Figure 2-8: MED31 protein remaining (top) and protein quantification via ImageJ 
analysis (bottom) following MED31 knockdown. Western blot represents whole cell 
lysates of adipogenic-differentiated cells collected 7 days post-transfection. All data 
points represent the average of three biological replicates and data is normalized to 






Figure 2-9: Phase contrast (top) and color micrographs (middle) of adipogenic-
differentiated hMSCs at 7 days post-transfection. Staining of lipid droplets was 
performed using Oil Red O. Lipid vesicles are indicated with arrows. Oil Red O stain 
extraction (bottom). All data points represent the average of three biological 








Figure 2-10: qRT-PCR of early fat marker srebp-1c (top; P = 0.0016) and 
adiponectin (bottom; P = 0.0306). All data points represent the average of three 
biological replicates and data is normalized to gapdh for each sample. Error bars 







Figure 2-11: Loss of MED31 disrupts the balance between self-renewal and 
differentiation in hMSCs. 
2.4 Conclusion 
2.4.1 MED31 Critical to Balance and Proper Differentiation of MSCs 
Transcriptional control requires a delicate balance between gene activation and 
gene silencing. This balance is especially critical in a self-renewing population of cells 
that has the potential to differentiate down multiple lineages. If misregulated, cells will 
improperly differentiate or proliferate, leading to developmental defects or cancer. Here 
we report the role of MED31 in the maintenance and regulation of mesenchymal stem 
cell state. Reduction of MED31 by siRNA-mediated knockdown demonstrates a role for 
MED31 in maintaining the metabolism and proper differentiation of MSCs. MED31 
appears to be critical for differentiation of hMSCs suggesting an important role for the 
subunit in transcriptional activation. 
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MED12 AND ADIPOGENESIS 
 
3.1 Background 
Eukaryotic gene expression is a delicate balancing act that steers a stem cell either 
toward self-renewal or differentiation down any number of possible lineages. The central 
regulator of this process is the Mediator of RNA polymerase II (RNAP II), also known as 
the Mediator complex. This highly-conserved complex is composed of 30 subunits in 
humans3 and, together with cohesin, forms a protein bridge that links transcription factors 
found at linearly-distant DNA elements to cell type-specific gene promotors. After 
forming a chromatin loop between enhancer-associated gene regulatory elements and the 
pre-initiation complex14, Mediator recruits RNAP II to begin gene transcription. 
Mediator’s subunits are divided among four distinct modules: the head, middle, 
tail, and kinase9. The head and middle modules interact with RNAP II and the pre-
initiation complex while the tail module interacts with enhancer-bound transcription 
factors2. Taken together, these three modules form what is termed “core Mediator.” The 
four-subunit kinase module, however, can dissociate itself from the core8,37. Although the 
mechanism that triggers the kinase module’s dissociation from the rest of Mediator is not 
entirely understood, it appears to have a context-dependent role in regulating core 
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Mediator’s activity: activating Mediator in some circumstances54 and repressing it in 
others30,51,152. 
The Mediator kinase module is composed of four subunits, three of which have 
mutually-exclusive paralogs: MED12/L, MED13/L, CDK8/19, and Cyclin C. Of these, 
MED12 stands out as a particularly active subunit. MED12 has been associated with 
many cancers86,87, and several MED12 mutations have been implicated in phyllodes 
tumors of the breast102,103,106,107,153,154, uterine leiomyomas68,89,99–101,155,91–98, and prostate 
cancer108–110. MED12 is also a factor in FG (Oppitz-Kaveggia) syndrome117, Lujan 
syndrome118, and Ohdo syndrome119; each of which is X-linked (MED12 is located at 
Xq13.1) and is associated with intellectual disability. The breadth of different diseases 
tied to MED12 may be due to the subunit’s responsibility in activating CDK8/19’s kinase 
activity64. 
To date, MED12 has been found to associate with super-enhancers, interact with 
NANOG, SOX2111, and PRC1 in pluripotent stem cells112, interact with Wnt/β-Catenin in 
core Mediator recruitment to cell type-specific genes49, maintain HSC viability26, and 
interact with SOX10 in glial cells40. This all suggests that MED12 is an indispensable 
component of stem cell state regulation. In this paper, we explore a new potential 
interaction between MED12 and PPARG in human adult adipose-derived stem cells 
(ASCs) undergoing adipogenesis. PPARG is the central regulator of adipogenesis, and 
this finding, in addition to being novel, is important for the field of clinical medicine. The 
discovery of new interactions between gene expression regulators like the Mediator 
subunit MED12 and other transcription factors advances our understanding of 
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multipotent stem cell regulation, moving us closer to the application of adult stem cells as 
a safe and effective tool of regenerative medicine. 
3.2 Methods 
3.2.1 Cell Culture 
Human adipose-derived mesenchymal stem cells (hASCs) were maintained in 
MEM-α containing 16.9% fetal bovine serum, 1% Penicillin and Streptomycin, and 1% l-
Glutamine. Cells were cultured in a humidified incubator at 37 °C and 5% CO2. The 412 
donor cells were isolated from a normal, healthy donor and were characterized and 
provided by Dr. Bruce Bunnell and his lab at Tulane University School of Medicine. The 
cell line used had no further donor information disclosed to prevent data biases. For in 
vitro adipocyte differentiation assays the cells were cultured in AdipoQual™ Medium 
(LaCell: LaADM-500) for the duration of the differentiation protocol. After reaching the 
terminal time point, the cells were fixed in formalin and stained with Oil Red O. Levels 
of adipogenic differentiation were quantified by extracting Oil Red O stain using 
isopropanol and read at 544 nm. Stain extractions were normalized against the protein 
content of the samples collected using RIPA buffer and quantified using Bradford assays. 
Assays were performed in biological triplicates. Statistical analysis was performed using 
unpaired, two-tailed t-tests. 
3.2.2 Transient Transfections and Small Interfering RNAs 
Human ASCs were seeded at approximately 40% confluence and transfected 24 h 
later with 10 µM stock concentrations of Med31 siRNA (Thermo Fisher; 4392420) or a 
scrambled siRNA negative control (Thermo Fisher; 4390843) using Lipofectamine 
RNAimax (Invitrogen) following the manufacturer’s protocol. 
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3.2.3 RNA Extraction, cDNA Synthesis, and qRT-PCR 
Total RNA was extracted using TRIZOL reagent (Invitrogen) following the 
manufacturer’s protocol. For microarray analysis, total RNA was extracted using 
RNeasy® Mini Kits (Qiagen) following the manufacturer’s protocol. cDNA was 
synthesized using qScript™ cDNA SuperMix (Quanta Biosciences) following the 
manufacturer’s protocol. Quantitative reverse transcription-PCR (qRT-PCR) was used to 
quantify transcript expression levels for med12 and pparg. qRT-PCR was performed 
using PowerUp™ SYBR© green master mix as designated by the manufacturer’s 
protocol on the Applied Biosystems StepOnePlus™ qRT-PCR System. Gene expression 
levels were normalized to gapdh using CT values. Fold changes and relative remaining 
transcript were calculated using the 2−𝛥𝛥𝐶T method. Results were reported as an average 
of three or more biological replicates with error bars denoting the standard error of the 
mean (SEM). 
3.2.4 Western Blotting 
Human ASCs were seeded at 3 × 105 cells per 10 cm dish and cultured overnight. 
Upon reaching terminal time point post transfection with Lipofectamine® RNAiMAX, 
the cells were washed twice with PBS and harvested on ice using 400 µL RIPA lysis 
buffer (Abcam) supplemented with Halt™ Protease & Phosphatase Inhibitor Single-Use 
Cocktail (Thermo). Whole cell lysates were agitated for 30 min at 4 °C and then 
centrifuged for 20 min at 12,000 RPM at 4 °C. Protein samples were quantified using 
BSA standard curves generated using Bradford assays. SDS-PAGE was performed using 
a Mini-PROTEAN® TGX™ 4-15% gel (Bio-Rad) and a standard protocol. Proteins were 
transferred onto a PVDF membrane at 100 V for 1 hr according to a standard protocol. 
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After transfer, membranes were cut into designated pieces and blocked for 2 h in 5% milk 
in 1× TBS with 0.1% Tween®-20. The membrane was probed overnight with primary 
antibody (1:1000 MED12; 1:500 PPARG; 1:3000 GAPDH; 1:1000 TUBA1A), washed 5 
times, and probed with secondary antibody (1:1000). Blots were developed using ECL 
and chemiluminescence. The primary antibodies used: MED12 (Bethyl; A300-774A); 
PPARG (Cell Signaling; 81B8); GAPDH (Abcam; ab9485); TUBA1A (Abcam; ab4074). 
3.2.5 AlamarBlue Cell Proliferation Assay 
Human ASCs were seeded at 4000 cells per well on 24 well tissue culture treated 
plates. The hASCs were transfected 24 h post seeding and allowed to incubate for another 
72 h following transfection. After 72 h, the alamarBlue assay was performed as instructed 
by the manufacturer’s protocol. Fluorescence readings were recorded at 560/590 nm on a 
Cytation™ 5 plate reader (BioTek). 
3.2.6 Live/dead Assay 
A cell viability assay was performed using ReadyProbes® Cell Viability Imaging 
Kit (Life Technologies) following the manufacturer’s protocol for untreated, negative 
control, and MED31 knockdown cells. Images were taken on the EVOS FL imaging 
system and analyzed using ImageJ software. The counted nuclei of both dead (red) and 
live cells (blue) were averaged for six biological replicates and a t-test was used to 
calculate significance. 
3.2.7 Immunofluorescence Staining 
HASCs were seeded at 4000 cells per well on a 24 well tissue culture treated 
plate. The hASCs were transfected 24 h later and incubated for another 72 h. After 72 h, 
the Alexa Fluor® 555 Phalloidin (Life Technologies, A34055) and DAPI (Thermo Fisher 
62 
Scientific, 62248) staining was performed using the manufacturer’s protocol. Phalloidin 
was diluted to 1:40 and DAPI to 1:2000. Plate was imaged using a Cytation™ 5 plate 
reader (BioTek). 
3.2.8 Statistical Analysis 
Statistical analysis was performed using a Student’s two tailed t-test when 
appropriate. All error bars represent standard error of the mean. 
3.3 Results 
3.3.1 Kinase Subunit Expression Fluctuates During hASC Adipogenesis 
Differentiation is a well-orchestrated process that relies on the convergence of 
environmental factors, cell signaling, transcription factors, and gene expression 
regulation to produce a nearly irreversible alteration of a stem cell’s gene expression 
profile, leading to an overall change in the stem cell’s cellular identity. Adipogenesis, is 
the process of a multipotent stem cell differentiating into a mature adipocyte capable of 
accumulating and storing fatty acids within lipid vesicles. In order to establish a baseline 
for hASC adipogenesis, cells were characterized across four timepoints: day 0, 7, 14, and 
21 days following the induction of adipogenesis (Figure 3-1). Lipid vesicles, begin to 
emerge by day 7 as evidenced by phase-contrast imagine and Oil Red O staining. There is 
little difference in lipid vesicle expression between day 14 and day 21 of adipogenesis. 
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Figure 3-1: Phase contrast microscopy and Oil Red O staining of untreated hASCs at 
0-, 7-, 14-, and 21-days post-induction with adipogenic media. Images were captured 
at 10x magnification. 
Mediator is understood to play a critical role in cell type-specific gene expression, 
and this role includes regulating activity on the part of the kinase module. In order to 
establish the Mediator kinase module subunits as participants in regulating 
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differentiation, we first sought to establish baseline expression of the four kinase module 
subunits (MED12, MED13, CDK8 and CCNC) over the course of adipogenesis prior to 
and  7, 14, and 21 days after inducing adipogenesis (Figure 3-2, Figure 3-3, Figure 3-4, 
Figure 3-5, and Figure 3-6). MED12, MED13, and CDK8 are highly expressed prior to 
inducing adipogenic differentiation, indicating probable involvement in the transition 
from multipotency to a differentiation program. MED12 and CDK8 then decrease in 
expression and reach a low point by day 14 before being upregulated again at day 21. 
These data suggest that MED12 and CDK8, rather than MED13, are required not only in 
the initiation of adipogenesis but perhaps also in the maintenance of mature adipocytes. 
These subunits may play less of a role in the differentiation process as well given their 
reduced expression over the course of adipogenesis. 
65 
 
Figure 3-2: Western blots showing protein expression of kinase module subunits 
MED12, CDK8, and MED13 in untreated hASCs at day 0-, 7-, 14-, and 21-days post-




Figure 3-3: Quantitative RT-PCR of med12 in untreated hASCs at day 0-, 7-, 14-, and 
21-days post-induction with adipogenic media. The experiments were performed in 
biological and technical triplicates and the data were normalized to gapdh expression 
at their respective timepoints. 
 
 
Figure 3-4: Quantitative RT-PCR of med13 in untreated hASCs at 0-, 7-, 14-, and 21-
days post-induction with adipogenic media. The experiments were performed in 
biological and technical triplicates and the data were normalized to gapdh expression 















































Figure 3-5: Quantitative RT-PCR of cdk8 in untreated hASCs at 0-, 7-, 14-, and 21-
days post-induction with adipogenic media. The experiments were performed in 
biological and technical triplicates and the data were normalized to gapdh expression 
at their respective timepoints. 
 
 
Figure 3-6: Quantitative RT-PCR of ccnc in untreated hASCs at 0-, 7-, 14-, and 21-









































biological and technical triplicates and the data were normalized to gapdh expression 
at their respective timepoints. 
 
3.3.2 MED12 Knockdown Does Not Affect hASC Self-Renewal 
In order to test our assumptions that MED12 is involved not only in initiating 
adipogenesis but in adipocyte maintenance, we performed transient siRNA transfections 
to knock down MED12 expression in hASCs. Our MED12-siRNA transfections were 
effective at reducing med12 mRNA by nearly 80% (Figure 3-7) with an accompanying 
decrease in MED12 protein expression (Figure 3-8). AlamarBlue analysis revealed 
neglible change in hASC metabolism as a result of the knockdown (Figure 3-9). 
Additionally, cell viability (Figure 3-10) and morphology (Figure 3-11) appeared to be 
unchanged as a result of the knockdown. These results suggest that neither the transient 
transfection nor the decreased expression of MED12 significantly impacts hASC self-





Figure 3-7: RNA-level validation of siRNA-mediated MED12 knockdown via qRT-
PCR 72 hours post-transfection. The experiments were performed in biological and 





























Figure 3-8: Protein-level validation of siRNA-mediated MED12 knockdown via 
western blot 72 hours post-transfection (top). Quantitative analysis was performed 
using ImageJ (bottom). Data were normalized to GAPDH. Only single datapoints 




























Figure 3-9: AlamarBlue assay performed 72 hours post-knockdown. Metabolic 
activity is not significantly reduced in hASCs in the MED12 knockdown. Experiment 




Figure 3-10: Live-dead staining of hASCs 72 hours post-knockdown. Cell viability is 





Figure 3-11: DAPI and phalloidin staining of hASCs 72 hours post-knockdown. 
Images were captured at 10x magnification. Cellular morphology is not significantly 
impacted by MED12 knockdown. 
3.3.3 MED12 Knockdown Leads to Decreased Adipogenesis of hASCs 
Given the efficacy of our transfection system and its low impact on hASC 
viability and proliferation, we then characterized hASCs undergoing adipogenesis during 
MED12 knockdown. First, we performed microscopy and Oil Red O at the 7-day and 14-
day timepoints following MED12 knockdown and induction of adipogenesis. 
Adipogenesis at the 7- and 14-day timepoints is clearly reduced following the knockdown 
of MED12 (Figure 3-12). The efficacy of our knockdowns in these adipogenesis assays 
were similar to that observed in the self-renewal assays (Figure 3-13). After validating 
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the MED12 knockdown over time, we characterized the protein expression of the central 
regulator of adipogenesis, PPARG, and found that its expression was downregulated in 
the MED12 knockdown (Figure 3-14, Figure 3-15). These data confirm a role for 
MED12 in initiating adipogenesis, but further experimentation was required to explore 
the question of MED12’s declining role during adipogenesis and its increasing 
importance for adipocyte maintenance. 
 
 
Figure 3-12: Phase contrast and Oil Red O staining of hASCs undergoing 







Figure 3-13: Protein-level validation of siRNA-mediated MED12 knockdown via 
western blot (top). ImageJ analysis of MED12 knockdown 14 days post-
differentiation (bottom). Data were normalized to GAPDH. Experiment was 




























Figure 3-14: Western blot of PPARG 3-, 7-, and 14-days post-induction. PPARG 




Figure 3-15: ImageJ analysis of PPARG at 3-, 7-, and 14-days post-induction. 
PPARG expression appears to be reduced in the MED12 knockdown. 3- and 7-day 
timepoints were normalized to TUBA1A. 14-day timepoint was normalized to 



























3.3.4 MED12 Plays a Role During Early Adipogenesis 
We next sought to explore MED12’s changing role in adipogenesis over time. A 
set of experiments were devised that would delay MED12 siRNA transfection to 3 days 
(3d) and 7 days (7d) after induction of adipogenesis in addition to a standard 24-hour pre-
induction (PD) group as a control (Figure 3-16). Each group was collected at 14-days 
post-induction and characterized via Oil Red O staining and qRT-PCR. After validating 
the MED12 knockdowns via endpoint PCR (Figure 3-17), we performed Oil Red O 
staining (Figure 3-18) and stain extraction (Figure 3-19). Lipid vesicle staining appears 
to be reduced in the PD and 3d groups compared to a scrambled siRNA control, but the 
7d group revealed an insignificant change on lipid vesicle staining compared to the 
scrambled siRNA control. This evidence suggests that by day 7 of adipogenesis, there is 
less of a requirement for MED12 in directing gene expression driving hASC 
differentiation. The expression of pparg was then compared at each timepoint (Figure 
3-20). Each differentiation timepoint saw a significant decrease in pparg mRNA 
expression compared to the scrambled siRNA control except for the 7d group which saw 
its expression mostly unchanged compared to the control. This marked shift in pparg 
expression upon MED12 knockdown 7-days post-induction, taken together with the 
microscopy and stain extraction data, does not rule out a potential role for MED12 in 
maintaining adipogenesis and may even point toward an interesting relationship between 
MED12 and PPARG. The sharp increase in pparg expression and the similar lipid vesicle 
staining in the 7d group suggest the existence of a compensatory mechanism for PPARG 








Figure 3-17: Endpoint RT-PCR of gapdh and med12 for the pre-induction (PD), 3-





Figure 3-18: Phase-contrast microscopy (left) and Oil Red O staining (right) for the 
pre-induction MED12 knockdown and two post-induction MED12 knockdown 









Figure 3-19: Stain extraction performed for the pre-induction (PD), 3-days post-
induction (3d), and 7-days post-induction (7d) MED12 knockdown. PD p = 6.08E-05. 

































Figure 3-20: Quantitative RT-PCR validation of med12 knockdown (top) and 
characterization of pparg expression (bottom) for the pre-induction (PD), 3-days post-
induction (3D), and 7-days post-induction (7D) MED12 knockdown. Data were 
normalized to gapdh. Med12 p < 0.05. Pparg p > 0.05. 
3.4 Conclusion 
The Mediator complex is an indispensable part of cell type-specific gene 
regulation in hASCs, and its regulation guides individual cells toward either self-renewal 



















































results point to MED12 involvement beyond the point of cell fate determination and into 
the maintenance of differentiated adipocytes. Though these data alone are not sufficient 
to link MED12 and PPARG via protein-protein interactions, it has illuminated the 
possibility that these two critical regulators act in concert during the course of 
adipogenesis even into the later stages of differentiation. 
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CONCLUSIONS AND FUTURE WORK 
 
4.1 Conclusions 
The study of Mediator is critical for regulating gene expression, the process 
through which stem cell self-renewal and differentiation is governed. Therefore, 
understanding Mediator is a requirement for elucidating stem cell behavior. Work in this 
area is accelerating, particularly the study of Mediator’s kinase module, which possesses 
subunits responsible for many well-documented cancers and diseases, but the kinase 
module’s role remains poorly defined. 
Before committing fully to researching the kinase module subunit MED12, 
previous work on Mediator’s smallest subunit, MED31 (Figure 2-1), was completed. In 
order to establish a role for MED31 in human adult-derived stem cells, we performed 
siRNA-mediated knockdowns and validated efficiency for depleting MED31 transcript 
(Figure 2-2) and reducing protein expression (Figure 2-3) while characterizing its effects 
on stem cell viability (Figure 2-4 and Figure 2-5). After proving the knockdown 
system’s efficacy, the genome-wide effects of the MED31 knockdown were 
characterized using microarray analysis, finding that the majority of genes affected by the 
knockdown involved cell cycle and self-renewal (Figure 2-6). The knockdown was 
further characterized through cell culture, revealing a decrease in lipid vesicle formation 
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(Figure 2-9) and adipogenesis marker expression (Figure 2-10) in the MED31 
knockdown group. These results showed that MED31 disrupts the delicate balance 
between self-renewal and differentiation in mesenchymal stem cells (Figure 2-11). Such 
results are likely due to a change in Mediator’s structural conformation brought about by 
a reduction in available MED31 protein considering that MED31 is a middle module 
subunit.  
Following the report of observations made about MED31 in mesenchymal stem 
cells, we pursued the far larger MED12 subunit implicated in many female cancers, 
developmental diseases, and regulation of hematopoietic stem cells. With interest 
surrounding the kinase module growing, we first sought to characterize adipogenesis 
across four timepoints in adipose-derived stem cells (Figure 3-1) and kinase module 
subunit expression at both the protein (Figure 3-2) and mRNA level for MED12 (Figure 
3-3), MED13 (Figure 3-4), CDK8 (Figure 3-5), and CCNC (Figure 3-6). Expression of 
each of the subunits across 21 days of adipogenic differentiation revealed an interesting 
trend. The level of expression of all four subunits increased over time, reaching the 
highest levels at the final day 21 timepoint. MED12 and MED13 fluctuated wildly 
between the different timepoints, prompting further investigation into MED12’s effects 
on adipogenesis. MED12 levels were diminished using an siRNA-mediated knockdown 
and validated at both the mRNA (Figure 3-7) and protein levels (Figure 3-8). The 
knockdown did not adversely affect stem cell metabolism (Figure 3-9), viability (Figure 
3-10), or morphology (Figure 3-11). However, the MED12 knockdown did reduce lipid 
vesicle formation (Figure 3-12) and PPARG expression (Figure 3-14 and Figure 3-15), 
revealing the importance of MED12 in regulating adipogenesis. Pre-induction 
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knockdowns cannot fully address the role of MED12 in adipogenesis over time, as we 
had earlier observed MED12’s expression changes during the course of differentiation.  
Therefore, we performed delayed knockdown assays (Figure 3-16) that allowed for 
determining MED12’s changing role during adipogenesis from differentiation initiation 
to adipocyte maintenance. Starting MED12 knockdown 7 days after inducing 
adipogenesis resulted in lipid vesicle formation that was similar between the knockdown 
and control cells (Figure 3-19). Initially, this suggested that MED12’s influence ends 
early in adipogenesis, but this data combined with such a high level of PPARG 
expression after the day 7 post-induction MED12 knockdown (which has the potential to 
exceed control levels of expression) (Figure 3-20) points to a relationship between 
MED12 and PPARG that may function mechanistically as a relay between the two, with 
MED12 passing the baton to PPARG in later stages of adipogenesis after initiation is 
complete.  There is also the possibility for PPARG or other proteins working to 
compensate for the decrease in MED12 expression following the knockdown.  
This line of research is greatly aided by the tools and techniques of 
bioinformatics. Next generation sequencing is changing the way that molecular biologists 
approach the study of gene expression. As technology improves, so too do genome 
databases that molecular biologists rely on for designing primers and performing gene 
ontologies. Such techniques could have greatly aided research in Mediator, but the 
opportunity to learn bioinformatics arrived late during the degree program and covered 
the most foundational bioinformatics knowledge. However, that does not discount the 
knowledge gained as invaluable. 
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The sum of the work presented in this dissertation, at the very least, paves the way 
for more in-depth research to be performed. Currently, there is a lack of foundational 
research that focuses on the Mediator complex subunits and how they affect the self-
renewal and differentiation of clinically-relevant, human adult-derived stem cells. With 
Mediator as the central regulator of eukaryotic gene transcription, it deserves more 
attention in the study of cell state regulation, and this work adds to what is currently 
known with regard to our MED31 and MED12 studies. Little is understood about how 
the kinase module affects Mediator, let alone human adult-derived stem cells, so our 
findings in this area will attract the curiosity of other scientists willing to uncover the 
structure and function of this complex in development. The ultimate goal of stem cell 
research should be to deploy safe and effective stem cell therapies that are autologous, 
targeted, and tightly-controlled. Such therapies have the potential to be utilized for tissue 
regeneration, cancer mitigation, and even general life extension. This research is an 
important stepping stone toward that goal as Mediator is the key to unlocking the 
potential of stem cells for use in medicine. 
 
4.2 Future Work 
Keeping with our current focus on Mediator’s kinase module, what we have 
gathered from our research is that not only does MED12 affect adipogenesis in hASCs, 
but there is potential for interaction with the adipogenesis regulator PPARG. In order to 
determine if such an interaction exists, we must perform co-immunoprecipitation (co-IP 
assays). A series of co-IP assays would be conducted during self-renewal and during 
adipogenesis that could reveal a MED12-PPARG interaction. We would expect to see an 
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interaction between MED12 and PPARG during adipogenesis since both are important 
for regulating that process. Seeing such an interaction would confirm a role for MED12 
as a coactivator of adipogenesis. 
Next, PPARG expression has been the primary focus of our MED12 knockdown 
characterization. Though central to adipogenesis, PPARG is only one piece of the 
transcriptomic puzzle that is under the potential influence of a MED12 knockdown. A 
broader survey of all genes affected in differentiating hASCs can be accomplished 
through the use of RNA sequencing (RNA-seq). Such data would reveal the totality of 
MED12’s influence over gene expression, and that data combined with gene ontology 
would show which cellular processes are affected by MED12 during the course of either 
self-renewal or adipogenesis. RNA-seq data would present the most complete picture of 
how MED12 helps to direct stem cell fate. 
Further still is the question of MED12 as a coactivator of transcription. If MED12 
functions as a true coactivator on its own or with the kinase module, or even attached to 
the core Mediator complex, the best method for discovering such a role would be to use 
chromatin immunoprecipitation sequencing (ChIP-seq). ChIP-seq data analysis would 
highlight MED12 binding sites on chromatin throughout the genome, including 
promotors, super-enhancers, and any other locations. These discoveries could be 
enhanced with chromatin conformation capture (3C) in order to map chromatin looping 
which would reveal novel interactions between super-enhancers and key gene promotors 
in adipogenesis. RNA-seq, ChIP-seq, and 3C are great undertakings, representing a large 
risk with the potential for a large reward. 
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An outstanding question with regard to the Mediator kinase module is the role of 
the kinase module paralogs. Very little research exists regarding the paralogs and why 
they are necessary. As is true for most things in biology, if the kinase module paralogs 
were not necessary, they would not exist. This area of Mediator study is a frontier that 
needs to be explored, and exploring it will require rounds of knockdown assays to 
understand the function of each paralog and characterizations of the expression of each 
paralog in turn to look for any compensatory mechanisms at work. Such research should 
be combined with self-renewal and differentiation assays to further the understanding of 
the roles these unique subunits play in maintaining stem cell state. This work could be 
conducted with less investment of resources with a disproportionately higher payoff in 
advancing the field of Mediator research. 
Our future work represents a roadmap that, if pursued, would present a nearly 
exhaustive set of data for MED12’s involvement in cell state regulation in hASCs and 
would inevitably lead to further questions. Of course, this research seeks to clarify the 
piece of the stem cell regulation puzzle that represents MED12 and the Mediator kinase 
module. Overall, our current research and our proposed future work would contribute 
greatly to the body of knowledge of stem cell biology and how hASCs are regulated by 
the critical Mediator complex, pushing the field ever closer toward safe and efficacious 









This work was performed through an internship program at the National Center 
for Genome Resources in Santa Fe, New Mexico during the summer of 2018. 
A.1 Introduction 
Well before James Watson and Francis Crick’s revolutionary paper on the 
structure of the DNA double helix, biologists realized that biological organisms, and even 
entire species, rely on basic sequence information for survival. Since the cementing of the 
central dogma of molecular biology that states that biological sequence information 
largely flows from DNA to RNA to protein, scientists have sought to fully understand the 
nature of these information sequences both in what constitutes them and how they are 
utilized by molecular machinery to sustain cells and organisms. Today, we live in a post-
Human Genome Project world. Computers, which now dominate every aspect of life in 
developed countries, have propelled a once emerging interdisciplinary field, termed 
“bioinformatics,” to the forefront of the ever-accelerating march of biological 
understanding, pushing the boundaries of what we know about biological systems farther 
into the frontier. 
Bioinformatics concerns itself with both the content and expression of biological 
information, allowing for the mapping of entire genomes, discovery of genetic causes for 
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disease, illumination of genetic pathways and the transcriptome, and the understanding of 
both evolution and ecology. The field of bioinformatics relies not only on biologists, but 
also on statisticians, mathematicians, and computer scientists. Bioinformatics exists not 
within the realms of in vivo, in vitro, or in situ study, but within the realm of in silico: 
scientific advancement within silicon semiconductors156. 
The foundation for what would decades later become the field of bioinformatics 
began with the work of Frederick Sanger who is the fourth person in history to have ever 
achieved the honor of receiving the Nobel Prize twice—both of which happen to be in 
Chemistry. The first was awarded in 1958 for decoding the amino acid sequence of 
bovine insulin. The second, awarded in 1980, recognized his achievement in developing a 
procedure for the determination of nucleic acid sequences in DNA. Termed “Sanger 
sequencing,” this method involves the use of dideoxynucleosidetriphosphate chain 
terminators labeled with either fluorescent or radioactive dyes157. 
Though rudimentary by today’s standards, Sanger sequencing was the gateway 
technology that made the Human Genome Project possible. The National Institutes of 
Health, together with the United States Department of Energy, established the National 
Center for Human Genome Research initially led by none other than James Watson in 
1988. Slated to be a fifteen-year program, the Project’s objective revolved around 
mapping the entire human genome including establishing the full nucleotide sequence 
and the locations of all genes; however, the Project’s goals were actually two-fold. The 
second objective was to pioneer new developments in sequencing technology as the 
Project proceeded158. Necessity is the mother of invention, and the Human Genome 
Project created the necessity for modern sequencing and data analysis technology. 
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“Next generation sequencing,” or NGS, is the natural evolution of the work 
Sanger began with his sequencing method. NGS performs sequencing in a way that is 
massively parallel—i.e. collecting data on multiple similar polymerase reactions 
simultaneously—and gathers millions of reads, or sequence fragments, that are then 
assembled by a computer into a contiguous genome159. With the introduction of Illumina 
dye sequencing in 2007, the cost to sequence a single human genome has fallen from 
$1,000,000 USD in 2001 to almost $1,000 USD in 2017—a rate that surpasses Moore’s 
law160. 
Modern molecular biology’s dependence upon bioinformatics has increased 
considerably since the conclusion of the Human Genome Project. As of 2018, the 
National Center for Biotechnology Information stored the genomic information of nearly 
forty thousand unique species, all publicly available for download. Modern polymerase 
chain reaction (PCR) relies upon database tools such as PrimerBLAST to efficiently 
design functional primers. RNA sequencing (RNA-seq) is replacing microarray 
technology in differential gene expression analysis. The falling cost of genome 
sequencing has made the challenge of characterizing the small nucleotide polymorphisms 
(SNPs) responsible for certain devastating genetic diseases far more approachable to 
research scientists. Bioinformatics is also poised to elucidate some of the more arcane 
questions in biology, most of which reside in the growing field of metagenomics: 
questions about the human microbiome, the ecologies of microorganisms, and the 
evolution of macroorganisms. 
In the year 2000, the late Stephen Hawking said, “I think the next century will be 
the century of complexity.” As scientists, we should be prudent with regard to where our 
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fields are heading, and we should seek the skills we will require to sustain productive 
careers. Adapting to the influence of bioinformatics and the complexity it brings will 
require combining knowledge of computers, statistics, and molecular biology. 
A.2 Genomics 
Genomics involves the sequencing and analysis of genomes. Genomes are the 
complete record of potentially-expressible proteins an organism possesses, and molecular 
biology has become increasingly reliant upon genome sequence information over the last 
several decades. Even a technique as ubiquitous as PCR requires a genomic database to 
design primers. Understanding how genomic information is obtained is important for the 
molecular biologist seeking to utilize bioinformatics for its data-gathering and analytical 
power. Familiarity with the sequencing process is helpful, but it is far more important to 
understand how to analyze the data obtained from NGS. NGS data analysis processes are 
ever changing because the tools are ever changing. The process is an art, and the rules are 
established by consensus—however, the basic principles are static, and they serve as a 
guide. With journals wanting increasingly complex results, NGS is quickly becoming an 
indispensable tool to modern molecular biology because of the enormous amount of data 
it can yield and the stories that it can tell. 
A.2.1 The FASTQ File 
Modern bioinformatics depends upon massively parallel sequencing—that is, a 
large number of DNA sequence reads being generated simultaneously in the same run. A 
sequencer records the information it collects from the flow cells during sequencing in a 
digital format. This format, known as a FASTQ file, contains the sequence information of 
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every read obtained by the sequencing machine as well as quality information 
representing the confidence in the accuracy of each individual base call. 
FASTQ files are text files, but they rely on a specific set of formatting rules that 
allow them to be used in computer applications. An example of a FASTQ file is provided 
in Figure 5-1 below. The arrangement of information within a FASTQ file for each 
individual read is as follows: 
Line 1: Begins with @ (“at sign”) and is regarded as the first header. Information 
represented here relates to the sequencer used to perform the reads, the flow cell lane, the 
lane tile, and if the read is a member of a pair. 
 Line 2: Displays the nucleotide base calls. 
 Line 3: Begins with + (“plus sign”). The information from Line 1 is often 
repeated here, but leaving this line blank beyond the + reduces the file size of the FASTQ 
file. 




Figure A-1: A typical FASTQ file showing the header (line 1), base call sequence 
(line 2), second header (line 3), and the quality sequence (line 4). In most FASTQ 
files, the second header is represented only by “+” and left blank afterward in order to 
maintain smaller file sizes. Credit: Dr. Thiruvarangan Ramaraj, National Center for 
Genome Resources. 
A single FASTQ file can contain several gigabytes worth of reads, or discrete 
segment of genome captured by the sequencer. The length of each read depends on the 
sequencing technology used to capture the reads. For example, the sequencers built by 
Illumina tend to produce a high volume of short reads (hundreds of base calls per read), 
whereas PacBio’s technology captures a smaller number of long reads (millions of base 
calls). 
Reads form the basis for the idea of “coverage” in the bioinformatics sense. 
Coverage—also known as depth—is one of the most important factors in determining the 
sequencing methodology ideal for the organism a bioinformatician is trying to sequence 
and the budget allotted for the sequencing. Coverage can be defined mathematically, and 
the formula is provided below in Eq. A-1: 
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 𝐶𝑜𝑣𝑒𝑟𝑎𝑔𝑒 = 𝑁 ×
𝐿
𝐺
 Eq. A-1 
Where N is the number of reads obtained from sequencing, L is the average length of the 
reads, and G is the original genome length. For example, if a bioinformatician is 
interested in sequencing a human genome which is 3.0 billion base pairs long, and a 
sequencer produces 50 million reads with an average length of 500 base pairs, the 
coverage for this sequencing run is 8.3x. This means that there is an 8-fold sequence 
redundancy in the collected reads within the FASTQ file. While more coverage 
guarantees a more complete genome assembly, an increase in coverage comes at an 
increase in cost. 
A.2.2 Quality Control 
Genome assembly is a time-consuming and processor-heavy endeavor, so before 
proceeding to assembly using the FASTQ files obtained from sequencing, the files must 
first be examined for quality. Fortunately, as stated above, FASTQ files possess an 
inherent quality record for every base call, so all that is required is software that can parse 
that data and present it in a human-readable format. 
This quality record is represented in the fourth line of the FASTQ file as a Phred 
score. The system of Phred quality scoring was developed during the Human Genome 
Project as a way to efficiently measure the probably of incorrect base calls in high-
throughput data. The Phred score is calculated by the following equation Eq. 4-2161: 
 𝑞 = −10 × log10(𝑝) Eq. 4-2 
Where q is the quality score of the base call and p is the estimated probably that the base 
call is incorrect. This means that a base call with a Phred score of 40 has a 1 in 10,000 
chance of being wrong161. In order save space within FASTQ files, Phred scores utilize 
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the ASCII character chart to represent the quality score of each base call as a single 
character. That chart is provided in Figure A-1 below162. 
Table A-1: ASCII character table utilized by the Phred score system162. 
 
 FastQC is a free Java application developed by the Bioinformatics Group at the 
Babraham Institute in the United Kingdom. FastQC examines high-throughput data from 
a FASTQ file and compiles the quality control data into an HTML file that can be opened 
by a web browser. One of the most important quality metrics, per base sequence quality, 
is shown in Figure A-2 below. FastQC can also show the frequency of gaps in the read 
sequences which are represented in the FASTQ by N’s. An N denotes a nucleotide for 
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which a base call could not be accurately assigned by the sequencer, and excessive gaps 
can be detrimental for assembly. 
 
Figure A-2: An example of very high quality FASTQ data. The Phred scores for each 
base call within each read are above 30. Each read in this FASTQ file was 101 bases 
long, and there was a total of 9,454,898 reads contained within the file. 
A.2.3 Genome Assembly 
Jigsaw puzzles are an enjoyable group pastime that is time consuming, often 
taking days or weeks to complete a single puzzle with a thousand pieces. Usually, the 
unassembled puzzle pieces come inside a box that has the complete picture printed on the 
cover which can be used as a reference in order to complete the assembly. Completing 
the jigsaw puzzle relies on the assemblers’ abilities to recognize patterns and shapes and 
interlock the pieces in the correct order. 
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Replace a group of people with a cluster of parallel processors, increase the 
number of pieces from a thousand to millions, and genome assembly operates essentially 
the same way. Instead of a forming a picture, genome assembly takes the reads stored 
within FASTQ files and assembles them into a FASTA file as a set of long, contiguous 
sequences. Ideally, each contiguous sequence is a full chromosome. Fortunately, the logic 
and speed of modern computers grants them advantages over human brains even for 
computer processors that are not working in parallel. 
This advantage manifests itself in the mathematical and computational principle 
known as graph theory. Graph theory employs graphs to establish relationships between 
objects. Graphs are mathematical representations composed of nodes or vertices 
connected together by edges or lines. The modern approach to assembling short-read 
Illumina sequences is by solving via a de Bruijn graph. 
In order to understand how using a de Bruijn graph aids in genome assembly, the 
concept of the k-mer must be introduced first. Suppose that an Illumina sequencer created 
a FASTQ file containing reads that are each one-hundred base pairs long. This read is 
referred to as a string, and its string length L is equal to 100. A k-mer is a substring—that 
is, a section of the original string whose length, k, is less than L. Any k-mer length 
between 2 and 𝐿 − 1 is possible. The number of possible k-mers obtained from a given k-
mer length k and for a given string length L is 𝐿 − 𝑘 + 1, which for 𝐿 = 100, and 𝑘 =
55, the number of k-mers per read is 46. Of course, if a k-mer length of 35 were chosen 
instead, the number of k-mers per read would be 66. The important caveat to remember is 
that each k-mer must overlap its adjacent k-mer in the read by 𝑘 − 1, meaning that a k-
mer will overlap its neighbor for every base call except once at the beginning or the end. 
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When applied to the de Bruijn graph, every single k-mer substring from every 
read is assigned to an edge of the graph while both connecting nodes are assigned the 
prefix or suffix of that substring. The k-mer sequence AGTCAATG would be represented 
by an edge in the graph, so the preceding node would be 𝑘 − 1 (AGTCAAT) and the 
following node would also be 𝑘 − 1 (GTCAAT). Thus, the two nodes are bridged by the 
k-mer sequence, and both the preceding and subsequent nodes overlap with edges 
representing other k-mers that connect to other nodes ad infinitum until all k-mers have 
been incorporated into the graph. Figure A-3 below illustrates this process, and is based 
on the explanation and figures authored by Compeau et al163. 
 
Figure A-3: An example of a de Bruijn graph being applied to the process of genome 
assembly. Each edge represents a k-mer substring, and each node either the prefix of 
the subsequent edge or the suffix of the preceding edge. Together, the edges of the 
graphs are the individual puzzle pieces used to solve the larger assembly. 
 
 Contigs and Scaffolds 
During the course of genome assembly, sequence reads are joined together into 
continuous sequences known as contigs. Each contig represents a section of the genome 
that has been rebuilt by a collection of overlapping reads, and for this reason, contigs are 
considered consensus sequences. The assembly of larger, more complete contigs is aided 
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by greater sequencing depth, because greater depth results in more sequence reads that 
may potentially overlap164. 
One method that overcomes the problem of sequencing depth is the paired-end 
read. This sequencing technology produces two reads for each sequence fragment that are 
separated from each other by a predefined genomic distance. Because each read pair is 
separated by such a distance, this enables the assembly of contigs into scaffolds—that is, 
a sequence composed of contigs and gaps of defined lengths which are denoted by “N.” 
Paired-end reads aid the overall accuracy of assembly software by reducing the assembly 
problems brought about by highly repetitive sequences or GC-rich sequences that are 
more difficult to read and thus suffer from decreased depth. Contigs and scaffolds are 
illustrated in Figure A-4164. 
 
Figure A-4: Paired-end reads are assembled into contigs and scaffolds. Gaps in the 
scaffold are denoted with “N.” 
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A.2.4 The FASTA File 
A FASTA file is produced once final assembly is complete. The FASTA is 
simpler than the FASTQ format as the former contains only two lines: 
Line 1: Begins with > (“greater-than”) and is header. Information represented here 
establishes what the following sequence information actually represents. 
Line 2: Displays the nucleotide sequence representing the assembled genome. 
A FASTA file containing a fully assembled human genome would provide a 
header for each chromosome followed by that chromosome’s sequence as shown in 
Figure A-5. 
 
Figure A-5: The beginning of the FASTA file for the med12 nucleotide sequence 
contained in human chromosome X showing the header (line 1) and assembled 




Before an assembled genome can be published, it must first be annotated. 
Annotation is the process whereby software identifies both the physical elements 
(structural annotation) and biological function of those elements (functional annotation) 
of an assembled genome. Structural annotation is concerned with locating and labeling 
genes, coding domain sequences, exons, introns, and promoters. Identification of 
genomic structures is performed either by using experimental evidence or ab initio—i.e., 
without experiment evidence. Often, experimental evidence-based approaches to 
structural annotation rely on sequence homology between similar species in order to 
identify genes; therefore, it is possible to annotate genes in an unannotated organism by 
using a close relative that has been previously annotated. Ab initio structural annotation 
relies on computer algorithms and machine learning to build probabilistic models which 
in turn allow predictions about gene locations to be made. Such methods rely on Hidden 
Markov Models or support-vector machines165. 
Functional annotation is responsible for assigning biological roles for each 
annotated structure. If an identified gene is either known or putative according to 
database information, assignments include the name of a particular gene, its role in a cell, 
and any motifs that the expressed protein may possess. Sometimes, functional annotation 
may identify a gene that expresses a protein of an unknown function. When annotating 
novel genomes, it is possible to find many genes identified structurally but that are 
deemed hypothetical: a nucleotide sequence that possesses the structural hallmarks of a 
gene but which has not been previously characterized165. The completeness of functional 
annotation relies heavily on experimental information supplied to and cataloged in online 
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databases by research scientists. This highlights the interdependence of bioinformatics 
and foundational molecular biology research. Annotation produces a general feature 
format (GFF) file. 
A.3 Transcriptomics 
As genomics concerns itself with assembling and studying genomes, transcriptomics 
concerns itself with transcriptomes. The transcriptome of an organism or a cell is the 
collection of transcribed messenger RNA (mRNA) molecules that that organism or cell 
possesses at any given time. That is, the transcriptome is the record of all genes currently 
being expressed by an organism. Transcriptomics is of great interest to the study of gene 
expression as it can reveal genome-wide changes in transcriptional control due to a 
knockout or knockdown experiment, and this has presented opportunities for 
advancement in many fields, particularly stem cell self-renewal and differentiation. 
A.3.1 RNA Purification and RNA-seq 
In order to sequence the transcriptome, RNA must be extracted from cellular 
material, leaving behind DNA, proteins, and lipids. Such extraction is commonly 
performed via the phenol chloroform extraction method. 
Of course, mRNA transcripts are not the only type of RNA present within a cell. 
Ribosomal RNAs (rRNA), which are required for mRNA translation by ribosomes but 
are not part of the transcriptome, account for a significant share of total RNA—enough to 
significantly overwhelm transcriptomic data with irrelevant sequences if allowed to be 
included in sequencing. Many commercially-available kits exist that deplete rRNA. 
Because rRNA sequences are identical, most of these kits function by hybridizing rRNA 
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to complimentary oligonucleotides and remove it either through precipitation or RNase 
degradation. 
After purification, the mRNA is fragmented and then reverse-transcribed into 
complimentary DNA (cDNA) followed by PCR amplification. This amplified cDNA is 
then sequenced and FASTQ files are generated as output that can then be analyzed166. 
A.3.2 RNA-seq Read Mapping 
There are three main strategies for analyzing RNA-seq data, and each relies on the 
availability of reference genomes or transcriptomes. The first method involves mapping 
RNA-seq reads to a reference genome, eliminating the need to assemble those reads into 
transcripts. Because of the presence of alternative splicing and the absence of introns, 
mapping directly to a genome is a computationally-intensive process. This method can be 
easily employed to study human mRNA samples due to the existence of assembled and 
annotated human genomes; however, if no genome annotation file exists, this method 
allows for the functional annotation of novel transcripts166,167. 
The second method involves mapping to a pre-existing annotated transcriptome. 
The advantage with this method is speed and a lower computational requirement since 
introns are no longer a factor. The disadvantage of this method is that it offers no way to 
discover novel genomes, unlike when mapping to a genome166,167. 
The third method requires the assembly of a transcriptome when no reference 
genome or transcriptome exists. Like in genome assembly, the RNA-seq reads are 
assembled into contigs and transcripts, and then the reads are mapped back to those 
transcripts, counted, and then functionally annotated166,167. 
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A.3.3 Differential Gene Expression Analysis 
Of course, like with genome assembly, the quality of RNA-seq data depends on 
sequencing depth, and greater depth comes at a cost. Also, in order for the obtained data 
to be statistically relevant, at least three replicates are required. 
The chief hurdle that must be overcome with the analysis of RNA-seq data is the 
problem of normalization. Not all genes are the same size, and not all genes are equally 
expressed. What this means is that genes that are either very large or very highly 
expressed will have disproportionately large numbers of reads that map to their 
transcripts. RNA-seq normalization employs a metric to differentiate high read counts as 
being due to high gene expression rather than large gene size, and this metric is known as 
RPKM: Reads Per Kilobase per Million mapped reads. The equation for RPKM is below 
(Eq. 4-3). 
 𝑅𝑃𝐾𝑀 = 𝐶 /(𝑁 × 𝐿) Eq. 4-3 
Where C is the number of reads mapping to a feature (transcript, exon, etc.), N is the 
length of the feature in kilobases, and L is the total number of mappable reads in millions. 
This concept is illustrated in Figure A-6. 
105 
 
Figure A-6: RPKM accounts for gene size, reads mapped to a gene, and total number 
of mappable reads in order to normalize RNA-seq data. 
Quality control for RNA-seq data involves using dimensionality reduction 
techniques to plot patterns of clustering. The techniques used include multidimensional 
scaling, principal component analysis, and histograms with dendrograms. Most of the 
statistical theory involving these quality control techniques is beyond the scope of this 
brief overview of bioinformatics disciplines, but more information about the 
bioinformatics application of principal component analysis can be found in a review by 
Shuangge Ma and Ying Dai168. 
Once the quality of the data has been determined, quantitative analysis can begin. 
Two of the most well-known programs for performing differential gene expression 
analysis are edgeR and DESeq2. What these programs do first is determine the normal 
variability in gene expression. Then, they compare the data points of the expression of the 
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experimental groups to determine their similarity in distribution. Finally, the distribution 
results are statistically analyzed to determine the p-values of the data to establish 
significance. For a more detailed explanation about how DESeq works in differential 
gene expression analysis, refer to the paper by Simon Anders and Wolfgang Huber169. 
A.4 Metagenomics 
Metagenomics is a new and growing field of research and bioinformatic 
techniques involving the study of communities of organisms and their gene compositions 
as a whole. The primary significance of the emergence is that for many decades, the 
study of prokaryotic organisms as taken place in isolated cultures and controlled 
environments. Now, through metagenomics, entire communities of microorganisms can 
be collected from soil samples, gastrointestinal tracts, or other places and their genetic 
information can be sequenced, revealing information about those communities such as 
the genes that exist in that community, the different populations present in that 
community, and how environment can play a role in the composition of the community. 
Metagenomics is the bioinformatic method by which microbiomes can be better explored, 
and it has the potential to help humans be better stewards of their own microbiomes, 
hopefully leading to a revolution in how broad-spectrum antibiotics are used and how 
certain environmental issues can be overcome. For more information on metagenomics, 
refer to the publication The New Science of Metagenomics by the National Research 
Council (US) Committee on Metagenomics170. 
A.5 Internship 
The Summer 2018 internship took place at the National Center for Genome 
Resources (NCGR) located in Santa Fe, New Mexico. NCGR grew out of the Human 
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Genome Project as an offshoot of the Los Alamos National Laboratory less than 40 miles 
away. Currently, NCGR operates as a non-profit research institute that focuses on the 
analysis of NGS data rather than on sequencing itself, and this is due to the Moore’s 
Law-style speed at which sequencing technology is improving. 
NCGR operates its own data center, and participants were allowed to see the 
servers in operation within their server room. All work performed for the internship took 
place on a small set of server blades that was named “Logrus,” inspired by the maze set 
in the Chronicles of Amber fiction written by Roger Zelazny who was a resident of Santa 
Fe for a number of years. Logrus ran a Linux distribution that was accessible via terminal 
emulators like PuTTY on laptops. 
Before the internship began, participants were required to take an online course 
on Linux to learn how to use the operating system and interact with the Linux shell using 
the Bourne Again Shell (Bash) command language. This was primarily meant to gauge a 
willingness to learn. Once the internship began, Bash was reintroduced, and participants 
were taught how to interface with the Logrus server. Figure A-7 shows the introduction 
to the command line interface in the Linux terminal. 
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Figure A-7: The command line interface on the 64-bit PuTTY terminal emulator. 
Shown is the user “jstraub” on the Logrus server and the process of basic 
familiarization with Bash commands and Linux file directories. 
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The average day at NCGR consisted of morning lectures and afternoon 
workshops, broken by a 90-minute break for lunch. The first two weeks of the six-week 
program involved genomics. Interns were instructed on the basics of NGS technology 
and approaches to sequencing, particularly those of Illumina and Pacific Biosciences. 
They were then taught the methods by which genomes are sequenced and assembled, 
including workflows. These workflows were then applied using terminal emulators to the 
Logrus server. 
The first real assignment after the necessary familiarization with the Linux 
environment, Bash, and the working directories was to assemble the genomes of five 
different strains of Staphylococcus aureus: MM66, MM66-4, MM61, MM25, and MV8. 
This was done as part of a two-week workshop on genome assembly. The sequence 
information supplied was in the form of Illumina GAII paired-end reads. The software 
used included SOAPdenovo and SPAdes, and the work was performed in a detached 
screen so that other work could be performed. A screenshot of SPAdes assembling the S. 
aureus MV8 genome is shown in Figure A-8 and Figure A-9. 
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Figure A-8: Active assembly of the S. aureus MV8 genome using the SPAdes 





Figure A-9: Active assembly of the S. aureus MV8 genome using the SPAdes 
software continued. This screenshot was taken during a mapping step. 
The FASTA file generated by SPAdes (named “scaffolds.fasta”) contained the 
assembled genome of S. aureus MV8. Of course, as revealed in Figure A-10 below, the 
genome was not entirely complete. The FASTA file contained 370 separate scaffolds 
which SPAdes could not accurately piece together, and this is due to the nature of 
shotgun sequencing—a problem that can be solved at the cost of increased sequencing 
depth. N50 is perhaps the most important metric taken into consideration which assessing 
overall completeness of any given assembly. N50 is defined as the largest length L such 
that 50% of all nucleotides are contained in contigs of sizes that are at least L. 
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Figure A-10: Analysis of the S. aureus MV8 FASTA file. The FASTA was 
composed of 370 scaffolds ranging from 80 to 297,298 nucleotides and totaling 
3,125,157 nucleotides. Less than 35% of the assembled scaffolds were of a size 
greater than 1,000 nucleotides, but of those scaffolds, only 0.22% of the nucleotides 
were gaps. 90.5% of scaffolds contained only a single contig, and the number of 
contigs numbered 457. The N50 contig length was 143,607 nucleotides, meaning that 
50% of nucleotides were contained in contigs larger than that length. 
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After conducting the assembly of Illumina reads, interns were instructed to 
assemble longer PacBio reads of Janthinobacterium using CANU. A screenshot of that 
process is shown in figure. 
 
Figure A-11: Assembly of Janthinobacterium PacBio reads. Most read lengths are 
between 1,000 and 1,999 nucleotides. 
HMMER was used to align the assembled prokaryotic genomes to the Pfam 
database. A screenshot of HMMER being used by the interns as seen in the Linux “top” 
program is shown in Figure A-12. Top is the main Linux program responsible for 
showing system usage statistics. RAST was then used to annotate the genomes both 
structurally and functionally and produce a GFF file (Figure A-13). 
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Figure A-12: The “top” command running in the main screen of the PuTTY terminal. 
Most user jobs consisted of running the “hammer” program in detached screens. 
%CPU usage of 200.0 equates to using the equivalent of two CPUs on a process. The 




Figure A-13: RAST performing annotation for the aligned genome to produce a GFF 
file. 
Created files that required use beyond the Linux environment could be placed into 
a directory named “www.” This directory could be accessed using a web browser such as 
Google Chrome (Figure A-14). 
116 
 
Figure A-14: A subfolder of the www folder contained within user jstraub’s home 
directory. 
The next week consisted of a workshop on variant calling which entailed the 
identification of genuine small nucleotide polymorphisms (SNPs) and differentiating 
those from sequencing errors. The Freebayes software was used to compare human 
samples against a human reference genome. The significance of this exercise was in 
showing the process for determining the allelic makeup of a sampled individual which 
has use in determining carrier status for genetic diseases such as Tay Sachs. 
The workshop on RNA-seq and differential gene expression immediately 
followed variant calling. First, human RNA-seq data was aligned to a human reference 
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genome using STAR. Then, FeatureCount was used to generate a count of all RNA-seq 
reads. Finally, differential gene expression analysis was performed using DESEQ2. 
Figure A-15 shows a principal component analysis of the RNA-seq data for quality 
control purposes. 
 
Figure A-15: Principal component analysis of RNA-seq data. The four different 
datasets are clustering together which indicates good quality data. 
The figure above was created using R. An entire workshop involving visualizing 
data using R was included in the internship. In the effort of keeping this chapter brief, the 
principal component analysis will serve as the only example of that work. Finally, a short 
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workshop on metagenomics concluded the internship, and this was coupled with a helpful 
lecture on the virtues of being a good software user in the relatively new field of 
bioinformatics. 
This internship not only allowed for a six-week stay in the beautiful state of New 
Mexico, but it revealed a new side of biology that is interested in big data problems—
problems that can only be solved by large computers, efficient software, and creative 
imaginations. Six weeks was not enough to gain any proficiency in the myriad techniques 
presented during the program except for Linux command line operation; however, the 
hands-on familiarity with the techniques presented was more than enough to justify the 
time spent participating in the program. That familiarity helped to cement a foundation 
upon which further bioinformatics training could be built. 
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APPENDIX B  
 
TABLE OF PRIMERS 
 
Table B-2: Primers used in qRT-PCR. 
Gene Sequence (5`→3`) Product 
Length (bp) 
Med31 F: GTTTGTTATGGCCGCTGCTG 
R: CCTCTTTGGGCAAGAAAATTAAGGT 
129 
Med12 F: CGAAAAGGGACAGCAGAAAC 
R: CCCATCCTCCCCACCTAAGA 
87 
Med13 F: TGTCCTGCTCCTTCACCTTTT 
R: GGCATAAGATAACTTGAAATGGGCT 
150 
Cdk8 F: GCCAAGAGGAAAGATGGGAAGG 
R: GCCGACATAGAGATCCCAGTT 
77 
Ccnc F: GCTGATTTGATCGAGGAGCG 
R: ATCCATTGCAAATAGTGGGAGC 
148 
Pparg F: GTGGTACTTTACGCCTCGGT 
R: GCTCGGTTACTCCCCGTTTC 
70 
Lpl F: CCGCCGACCAAAGAAGAGAT 
R: TAGCCACGGACTCTGCTACT 
117 
Srebp-1c F: CTCTTGAAGCCTTCCTGAG 
R: GCACTGACTCTTCCTTGAT 
138 
Adiponectin F: TTCCATACCAGAGGGGCTCA 
R: GAGTCGTGGTTTCCTGGTCA 
89 
Gapdh F: ACTAGGCGCTCACTGTTCTCT 
R: CAATACGACCAAATCCGTTGACT 
99 
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